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Stellingen 
behorende bij het proefschrift  
‘Evidence-based practice regarding the lumbosacral radicular 
syndrome’ 
 
 
1. Nederlandse huisartsen en neurochirurgen volgen goed hun richtlijnen 
aangaande het lumbosacraal radiculair syndroom. (dit proefschrift) 
 
2. Na operatie vanwege een lumbosacraal radiculair syndroom zijn 
patiënten (zeer) tevreden over de behandeling. (dit proefschrift) 
 
3. Systematisch doorzoeken van de literatuur (tot mei 2004) levert geen 
aanwijzingen voor een superieure behandeling bij het lumbosacraal 
radiculair syndroom. (dit proefschrift) 
 
4. Fysiotherapie bij het lumbosacraal radiculair syndroom levert na een 
jaar meer herstelde patiënten op dan geen fysiotherapie. (dit 
proefschrift) 
 
5. Fysiotherapie bij het lumbosacraal radiculair syndroom is geen 
kosteneffectieve toevoeging aan de huisartsenbehandeling. (dit 
proefschrift) 
 
6. De heilgymnasten van vroeger en de fysiotherapie van nu, het blijft 
hoofdzakelijk een kwestie van actief oefenen. 
 
7. Kwaliteit is geen kostenpost maar een investering. 
 
8. Fantasie is belangrijker dan kennis. (Albert Einstein) 
 
9. Iedereen heeft recht op elke medische behandeling, ongeacht wat deze 
kost. 
 
10. De genezing begint als de huisarts vraagt wat je er zelf aan denkt te 
gaan doen. 
 
11. Velen klagen over hun uiterlijk maar niemand over zijn verstand. 
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General introduction 
 
 
In general practice the lumbosacral radicular syndrome (LRS) is the most frequently seen 
specific low-back disorder. LRS is not life threatening, but does cause pain in the leg and 
disability, often resulting in utilisation of healthcare resources and absenteeism from work. 
In the literature LRS is also referred to as ‘sciatica’, ‘ischias’, or ‘ischialgetic pain’. These 
synonyms are considered to be vague and less specific terms and, if possible, should be 
avoided.1 The definition of LRS used in this thesis is as follows: LRS is a disorder with 
radiating pain in the leg below the knee in one or more lumbar or sacral dermatomes, and 
can be accompanied by phenomena associated with nerve root tension or neurological 
deficits.1-5 
 
Disc herniations are the most frequent cause of LRS, but other (more rare) causes include 
spinal or lateral recess stenosis, tumours and radiculitis.1,5 The incidence of LRS in the 
Netherlands is estimated at between 60,000 and 75,000 cases per year.1 The total (direct and 
indirect) costs of LRS in the Netherlands are estimated at 1.18 billion euro a year.1 
 
Most patients seeking medical care in the Netherlands usually first visit a general 
practitioner (GP), who is regarded as the ‘gatekeeper’ of the healthcare system. The majority 
of health problems presented to GPs are treated by the GPs themselves, and these GPs are 
responsible for most of the referrals to (para)medical specialists. Clinical practice guidelines 
have been advocated as a means to improve the quality of healthcare services, decrease 
costs, and/or foster evidence-based decision making.6-10 In 1996 the Dutch College of 
General Practitioners published their clinical guideline for LRS11 and updated it in 2005.5 In 
addition, a clinical practice guideline for LRS was issued in 1996 by the Dutch Institute of 
Quality Health Care;2 this LRS guideline is a consensus between 12 (para)medical specialties 
(physical therapists, general practitioners, orthopedic surgeons, anesthesiologists, 
epidemiologists, neurosurgeons, neurophysiologists, neurologists, radiologists, 
rehabilitation physicians, physical medical scientists, social medical scientists) involved in 
treating patients with LRS. 
 
There is consensus that treatment of LRS in the first 6 to 8 weeks should be conservative. 
Primarily, conservative treatment consists of adequate pain medication, giving information 
about the natural course of LRS (which generally is favourable), and stimulating the patient 
to continue normal daily activities. Many conservative treatments are available for treating 
LRS, and many patients are referred to physical therapy.1 
 
According to the guidelines for LRS, surgery can be recommended for patients with 
objective evidence of a disc herniation who have not responded to conservative 
treatment.5,11,12 If this is the case, the patient is usually referred to a neurologist or a 
neurosurgeon. In the Netherlands the neurosurgeon generally performs surgery in those 
patients with LRS caused by a disc herniation. 
 
In 1999 the Health Council of the Netherlands published recommendations for research to 
determine to what extent the current knowledge on LRS is utilised by the (para)medical 
specialties involved.1 In particular, the efficacy of guidance in the case of physical therapy 
needed to be investigated.1 
The overall objective of the research described in this thesis was to establish the GPs’ and 
neurosurgeons’ current management of patients with LRS compared with the guidelines, 
and to assess the effectiveness of physical therapy in addition to the GP’s care in patients 
with acute LRS. 
 
This thesis consists of eight chapters; because each chapter has been written as a separate 
article there may be some overlap in content between the chapters. 
 
The study presented in Chapter 1 is based on 63 GPs and 136 of their patients with LRS, 
and aimed to establish the GPs’ current policy in the diagnosis and treatment of LRS 
compared with their clinical guideline. Chapter 2 presents data compiled from 66 
neurosurgeons in the Netherlands and investigated to what extent neurosurgeons endorse 
the content of the LRS guideline. In Chapter 3 data are presented of the same 66 
neurosurgeons and 163 patients who had undergone surgery because of a herniated disc in 
the lumbar spine; this study evaluated the neurosurgeons’ current management of LRS 
patients who had undergone surgery in comparison with the LRS guideline. Chapter 4 
presents the 19-month follow-up data of these 163 LRS patients who had undergone 
surgery, and aimed to investigate the mid-long-term outcomes after surgery and to identify 
prognostic factors for persisting LRS complaints. 
 
Chapter 5 presents the results of our systematic review that was conducted to assess the 
effectiveness of conservative treatments in LRS when compared to placebo, inactive or no 
treatment, or compared to other forms of conservative care or surgery. Chapter 6 presents 
the design of a randomised clinical trial of conservative treatment (GP care and additional 
physical therapy) in patients with acute LRS. Chapter 7 presents the 1-year follow-up data 
of this trial which included 135 patients with LRS from 112 GPs (note: these are not the 
same GPs and patients presented in Chapter 1); this study aimed to assess the effectiveness 
of physical therapy in addition to GP care compared to GP care alone, in patients with acute 
LRS. Data on our economic evaluation are presented in Chapter 8 that aimed to assess the 
cost-effectiveness of physical therapy and GP care for patients with acute LRS.  
 
Finally, the General Discussion addresses the most important results of the studies, the 
study limitations and their implications. 
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Chapter 1 
 
General practitioners’ management of the lumbosacral radicular syndrome compared 
with a clinical guideline 
 
Pim A.J. Luijsterburg, Arianne P. Verhagen, Sigrid Braak, Anushka Oemraw, Cees J.J. 
Avezaat, Bart W. Koes. 
Eur J Gen Pract 2005;11:113-21. 
 
 
Abstract 
 
Objective To investigate the current treatment policy of general practitioners (GPs) in 
patients with a lumbosacral radicular syndrome (LRS) compared with their clinical 
guideline. 
Design A cross sectional survey. 
Methods Sixty-three GPs completed questionnaires about their treatment policy in 
individual LRS patients at baseline and at six months follow-up. Simultaneously, 136 LRS 
patients of these GPs were interviewed at baseline, and at three and six month’s follow-up. 
Results Of the 12 recommendations in the guideline related to history taking, four were not 
adhered to by the GPs in about 25% of the patients. Of the ten recommended physical 
examinations, three are not frequently carried out by the GPs. Almost 40% of the patients 
were referred to physiotherapy and 27% received muscle relaxants. 
Conclusion The majority of the GPs support the content of the LRS guideline. Overall, there 
was a good adherence with the guideline for history taking and physical examination, and a 
moderate adherence for treatment policy. 
 
Introduction 
 
Practice guidelines have been advocated as a means to improve quality, decrease costs, 
reduce variation, and/or foster evidence-based decision making.6-10 Guideline 
recommendations must be implemented to achieve the desired outcomes. To evaluate the 
implementation it is important to establish whether a profession, in general, accepts the 
guideline.9 Furthermore, insight in the current adherence of the professions is needed.13 
Reported rates of adherence with guidelines are extremely variable, ranging from 20% to 
nearly 100%, depending on the guideline and the definition of adherence.8,14,15 
 
In 1996 the Dutch College of General Practitioners published their evidence based clinical 
guideline for the lumbosacral radicular syndrome (LRS).2 Appendix A shows the summary 
of this guideline. Most patients seeking medical care in the Netherlands will first visit a 
general practitioner (GP), who is regarded as the ‘gatekeeper’ of the health care system. The 
majority of health problems presented to GPs are treated by the GPs themselves and they 
are responsible for most referrals to (para)medical specialists. 
 
The lumbosacral radicular syndrome, also called sciatica, is a disorder with radiating pain 
and/or neurological deficits in one or more lumbar or sacral dermatomes, often associated 
with back pain.2,4,16 LRS is mostly caused by a prolapsed disc, but other causes include spinal 
or lateral recess stenosis, tumours or radiculitis.1,2,4 The incidence of LRS in general practice 
in the Netherlands is estimated between 60,000 and 75,000 a year.1 
This study was aimed to establish GPs’ current policy in the diagnosis and treatment of LRS 
compared with their clinical guideline. 
 
Methods 
 
General practitioners 
GPs were recruited in the Rotterdam area from July to October 2001. After agreeing to 
participate the GPs were visited and helped to search their electronic medical records 
(EMD) for appropriate patients with LRS. 
 
Patients 
Patients with LRS were identified in the EMDs of the participating general practices based 
on the following inclusion criteria: diagnosed with LRS (ICPC-code L86) by their GP (see 
Appendix A) in the previous four months, age between 18 and 65 years, contactable by 
telephone, able to speak Dutch, and providing written informed consent. Patients with LRS 
complaints in the preceding six months were excluded. Also excluded were patients with a 
specific cause for leg pain other than LRS, or with a suspected prolapsed disc in the upper 
region of the spine. 
 
Questionnaires 
From the participating GPs data were collected concerning age, gender, working experience 
in years, type of general practice (solo practice or group practice) and to what extent they 
agree with the content of the guideline (almost entirely, partially and almost not). A 
questionnaire was developed to determine GPs’ current management of each participating 
LRS patient at baseline (study entry) and at six months follow-up. This questionnaire asked 
the GPs: 1) whether they had asked the patient the 12 questions related to history taking 
(yes or no), 2) whether the ten recommended physical examinations had been performed 
(yes or no), and 3) for a description of the prescribed treatment(s) e.g. medication, bed rest 
and referrals to (para)medical specialists. In both questionnaires GPs had the possibility to 
give additional explanations if considered necessary. 
 
After obtaining informed consent, the patients were interviewed by telephone at baseline, 
and at three and six month’s follow-up. The interviews established the patients’ 
characteristics, their types of complaints, and the treatment(s) prescribed by the GP. 
 
Statistical analysis 
Descriptive statistics were used to present the frequencies of the GPs subscribing to the 
content of the guideline and their current management of LRS patients compared with the 
guideline.  
 
We arbitrarily decided that there was no deviation from the LRS guideline when 60% or 
more of the GPs had answered ‘(almost) always’ to any item in the questionnaire that 
addressed their global opinion of the guideline. 
To establish to what extent the GPs adhere with the guideline, the following cut-off points 
were used for history taking, physical examination and prescribed treatment(s): 
• GPs’ adherence with the guideline for history taking was considered good, when at least 
50% of the patients was asked more than eight of the 12 questions, moderate when five 
to eight of the questions were asked, and adherence was considered weak when the GPs 
asked four or less questions. 
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• GPs’ adherence with the guideline for physical examination was considered good when 
six or more of the ten examinations were performed in at least 50% of the patients, 
moderate when four to six examinations were performed, and adherence was 
considered weak when the GPs carried out three or less of the examinations. 
• GPs’ adherence with the guideline for treatment was considered good, when there was 
only one or no deviation from the four types of recommendations (i.e. medication, bed 
rest, referral to (para) medical specialist), moderate when there was a deviation from 
two or three types of recommendations, and was considered weak when GPs deviated 
from all four types of recommendations. A deviation was considered present when 
treatment did not conform to the guideline in at least 25% of the patients. 
All data were coded and analysed using the statistical package SPSS for Windows (version 
10.0.7). 
 
Ethics 
The procedures of this study were in accordance with the ethical standards of the revised 
Helsinki declaration of 1983 and were approved by the Erasmus Medical Center ethics 
committee. 
 
Results 
 
GPs’ characteristics 
Of the 366 invited GPs, 63 GPs agreed to participate. Figure 1 summarizes GP and patient 
flow through the study. Reasons for not participating were: lack of time (30%), participating 
in another study (4%), no financial allowance for participating (2%), and various other 
reasons (30%), or reasons unknown (34%). The mean age of the participating GPs was 46 
(SD 7.6) years, 14% were female, and the mean work experience was 16 (SD 8.7) years. 
Twenty-seven of the 63 participating GPs agreed entirely with the content of the guideline, 
25 GPs partially and 11 GPs had not answered this question. 
 
Patients’ characteristics 
We identified 292 patients in the GPs’ EMDs (range 1 to 9 patients per GP) who were 
diagnosed with LRS during the previous four months. After applying the inclusion criteria, 
229 patients were invited to participate in the study. The reasons for exclusion were: 
diagnosed with LRS in the previous six months (43%), not speaking Dutch (16%), over 65 
years of age (14%), another specific cause for leg pain (14%) and being a patient of another 
GP in a group practice who did not participate in the study (13%). 
 
Finally, 136 patients gave written consent, their mean age was 47 (SD 13.4) years and 51% 
was female. No information was available about the non-participating patients. 
During the telephone interview, the patients reported that before they first consulted their 
GP the LRS complaints had persisted for (median) two weeks (IQR 7.2), and the time 
between the first consultation with their GP and the interview was (median) 14.6 weeks 
(IQR 16.1). 
 
 
 
 
 
 
Figure 1: Flow chart of GPs and patients. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1 lists the patients’ complaints at the first consultation with their GP, as reported by 
the patients during the baseline interview. 
 
Table 1: Complaints of the patients (n=136) at their first consultation with the GP, as reported by the patients at 
the baseline telephone interview. 
 
 At baseline, n (%) 
Back pain with irradiating pain to the leg 112 (82) 
Pain below the knee 110 (81) 
Sensory deficits in the leg 90 (66) 
Decreased muscle strength in the leg 87 (64) 
Decreased pain on rest 62 (46) 
Increased pain with daily activities 75 (55) 
Specific body position with more or less pain 109 (80) 
Reported a cause of the complaints 70 (52) 
Increased pain on coughing, sneezing or straining 67 (49) 
Urinary problems 13 (10) 
Saddle anaesthesia 52 (38) 
n= number (and percentage) of patients per complaint. 
 
Management of LRS patients 
At baseline, 40 GPs completed the questionnaire about the current management of 123 
patients (90%), and at six months follow-up 38 GPs completed this questionnaire about 121 
patients (89%). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
366 GPs invited 
63 GPs participating
303 GPs not participating
292 patients identified in EMDs
156 patients excluded
Baseline: 
• 136 patients from 41 GPs interviewed 
• questionnaires of 123 patients from 40 GPs 
At 6-month’s follow-up: 
• questionnaires of 121 patients from 38 GPs 
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Table 2 lists the questions asked at history taking and the physical examinations performed 
by the participating patients, as reported by the GPs at baseline based on their medical 
records (missing data ranges from 1-13%). 
 
Table 2: Questions asked at history taking and physical examinations performed by GPs in 123 patients (baseline 
data). 
 
 
 
Asked / performed, 
n (%) 
Not asked / not performed, 
n (%) 
History characteristics:   
Back pain with irradiating pain to the leg 123 (100) 0 (0) 
Pain below the knee 122 (99) 1 (1) 
Sensory deficits in the leg 120 (97) 3 (3) 
Decreased muscle strength in the leg 121 (98) 2 (2) 
Duration of complaints before first GP consultation 99 (80) 14 (11) 
Pain on rest 73 (59) 35 (28) 
Pain on daily activities 82 (67) 28 (23) 
Specific body position with more or less pain 89 (72) 30 (24) 
Cause of the complaints 114 (92) 5 (4) 
Pain on coughing, sneezing or straining 104 (85) 16 (13) 
Urinary problems 107 (87) 15 (12) 
Saddle anaesthesia 94 (76) 29 (24) 
   
Physical examinations:   
Physical inspection 94 (76) 27 (22) 
Active examination 90 (73) 32 (26) 
Test of Lasègue  107 (87) 16 (13) 
Test of Bragard 34 (28) 85 (69) 
Ankle tendon reflex 90 (73) 32 (26) 
Knee tendon reflex 88 (72) 33 (27) 
Sensory deficits in the foot 69 (56) 52 (42) 
Muscular strength of the big toe 48 (39) 72 (59) 
Walking on heels and on toes 71 (58) 49 (40) 
Crossed test of Lasègue 44 (36) 74 (60) 
n= number (and percentage) of patients (not) asked/(not) performed. 
 
In 23-28% of the patients the GPs did not ask four questions related to history taking: i.e. 
decreased or increased pain on rest, on daily activities, on specific body position, and the 
presence of saddle anaesthesia. Nevertheless, because these recommended questions were 
asked by the GPs in more than 50% of the patients, we concluded that the GPs’ adherence 
with the LRS guideline is good for history taking. 
 
Seven of the ten physical examinations were carried out by the GPs in more than 50% of the 
patients. The examinations for muscular strength of the big toe and the crossed test of 
Lasègue were performed in 39% and 36% of the patients respectively. Therefore, for the 
physical examinations we concluded that GPs’ adherence with the guideline is good. 
Table 3 lists the prescribed treatment(s) as reported by the GPs at baseline and at six-month 
follow-up. 
During the six-month follow-up the GPs prescribed medication for 82% of the patients, 
mostly NSAIDs (54%). In addition, they prescribed paracetamol for 15% of the patients and 
muscle relaxants for 27% of the patients. 
 
Table 3: Treatments prescribed treatment(s) by 40 GPs in 123 patients at baseline, and by 38 GPs in 121 patients at 
the 6-month follow-up. 
 
 At baseline 
(40 GPs/123 pats.), n (%) 
6 months 
(38 GPs/121 pats.), n (%) 
Medication 99 (80) 2 (2) 
Bed rest 18 (15) 1 (0.8) 
Referral for physiotherapy 45 (37) 14 (12) 
Referral for manual therapy 2 (2) 1 (0.8) 
Referral for X-rays 2 (2) 0 
Referral to orthopedic surgeon 2 (2) 0 
Referral to neurologist 30 (24) 7 (6) 
Referral to neurosurgeon 1 (1) 0 
Other 4 (3) 7 (6) 
n= number (and percentage) of patients. 
 
The LRS guideline, however, recommends paracetamol as first choice followed by NSAIDs. 
Moreover, the guideline claims that there is no indication for prescribing muscle relaxants. 
The GPs prescribed bed rest in about 15% of the patients during the six-month follow-up. 
The guideline still recommends bed rest as treatment for severe LRS complaints. However, 
recent data indicate that this recommendation may be outdated.17 
The GPs referred 49% of the patients to physiotherapy during the six-month follow-up. The 
guideline LRS, however, claims that physiotherapy is (as yet) not a treatment alternative for 
LRS. 
During the six-month follow-up the GPs referred about 35% of the patients to a medical 
specialist: 40% these referrals (missing 60%) took place after a median period of eight (IQR 
11) weeks. The majority of these referrals (65%) were made before eight weeks after the first 
consultation with the GP. However, due to the high percentage of missing data we were 
unable to determine whether overall the GPs deviated from the recommendation ‘referral to 
specialist’. Because the GPs deviated from three (i.e. medication, bed rest, and referral to 
paramedical specialists) of the four types of recommendations, we concluded that the GPs’ 
adherence with the guideline for treatment policy is moderate. 
 
Discussion 
 
Fifty-two of the 63 participating GPs agree (at least partially) with the content of the LRS 
guideline. GPs’ adherence with the guideline is good for history taking and physical 
examination, and moderate for prescribed treatment. The GPs prescribed muscle relaxation 
medication and physiotherapy in 27% and 49% of the patients, respectively. 
 
Some limitations of the study need to be discussed. Firstly, simply inviting GPs to 
participate in this study could have introduced selection bias in that motivated GPs may 
already largely adhere with the LRS guideline. 
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Furthermore, because GPs were recruited without consideration of the type of general 
practice or gender, GPs working in a solo practice are over-represented (71% versus 44% for 
the entire Netherlands).18 The percentage of female GPs in this study is slightly under-
represented (14% versus 21% for the entire Netherlands).18 Therefore, it is possible that our 
results under- or overestimate the acceptance of the GPs’ guideline for LRS, but we cannot 
confirm this. 
 
The LRS patients were identified retrospectively (in the previous four months) using the 
GPs’ EMDs and searching for ICPC-code L86. Some patients with LRS may have been 
missed because the GPs coded them differently, e.g. as ICPC L02 (back complaints). It is 
reported that the incidence of LRS in general practice in the Netherlands is three patients in 
three months.1 In 45 practices we identified 229 LRS patients, giving an incidence rate of 
five LRS patients in four months. Therefore we assume that no major patient selection 
occurred because of the partially retrospective design. 
 
Because the questionnaires used in the present study were specifically developed based on 
the GPs’ LRS guideline, no data on the reliability and validity of these questionnaires are 
available. Inherent to the retrospective design of this study there are some problems in the 
data collection from GPs and patients. GPs reports about their management in patients 
with LRS were based on their medical record and on their memory of the consultation. The 
patients answers were based on their memory only. But, we do not know in which way this 
influenced the results. 
 
The clinical guideline LRS evaluated was published in 1996 and is recently updated.5 
However, there are no major changes in the updated guideline except that bed rest is not a 
treatment option any more. The results of our study show that the GPs did not often 
prescribe bed rest, already. This means that the results from our study are probably 
comparable if we compare GPs’ management in our study with the updated clinical 
guideline LRS. Also, in the updated guideline more attention is paid about the information 
and advice given to the patients with LRS i.e. more positive messages aimed to change 
beliefs and behavior, this in accordance with the study of Chaudhary et al.19 
 
Conclusion 
 
This study shows that GPs adhere to a large extent with the guideline for history taking and 
physical examination, and to a moderate extent for prescribing treatment(s) for patients 
with LRS. 
Appendix A: Summary of the clinical guideline ‘Lumbosacral radicular syndrome’ of the Dutch College of General 
Practitioners (1996) 
 
Definition: The lumbosacral radicular syndrome: radiating pain and/or neurological deficits in one or more lumbar 
or sacral dermatomes, often associated with back pain; mostly caused by irritation and compression (traction) of 
the nerve root. 
History taking: Ask about: 1) localisation, radiation, intensity and duration of the pain, 2) influence of rest, 
movement and posture, 3) development of the complaints, 4) interference with daily activities caused by leg pain, 
5) decreased muscle strength and sensory deficits, 6) influence of coughing, sneezing or straining, 7) previous 
history of back complaints, and 8) urinary problems and saddle anaesthesia. 
Physical examination: 1) physical inspection (spine and pelvis), 2) active examination (ante-, retro-, lateroflexion), 
and 3) Lasègue sign and test of Bragard. If there is a positive Lasègue sign, decreased muscle strength or sensory 
deficits perform: 4) ankle tendon reflex and knee tendon reflex, 5) sensory examination of the lateral and medial 
side of the foot, 6) muscular strength of the big toe, walking on heels and toes, and 7) crossed test of Lasègue. 
Additional examinations: X-rays should only be ordered in case of suspicion on malignancy or a fracture due to 
osteoporosis. 
Evaluation: The lumbosacral radicular syndrome should be diagnosed if there are radiating complaints in the leg 
below the knee, plus one of the following findings: 1) a positive Lasègue sign (or Bragard), or 2) neurological 
deficits reducible to a single nerve root. 
Information and advice: Explain to the patient that radiating complaints are caused by a prolapsed disc that gives 
pressure on a nerve in the back. There is a favourable course in 80% of the patients with conservative care. Back 
pain may persist after the leg pain has gone. 
Mild complaints: Advice the patient to perform the usual daily activities but to avoid painful movements. 
Gradually increase the activities. 
Severe complaints: Strict bed rest (washing and toilet visits on bed) for two weeks. When the complaints decrease 
after a few days or two weeks, less strict bed rest (walking, washing and toilet visits allowed). Gradually increase the 
activities to normal level in six weeks and to patients’ level in six to twelve weeks. 
Follow-up: Check the patient with bed rest after two to four days. Evaluate the effect of treatment by checking 
Lasègue sign and the severity of the complaints. Check patients with severe complaints daily and subsequently at 
least once a week. Accompany the patient till full resumption of daily activities. 
Drug treatment: If desired: paracetamol (4-6 dd, 500mg), ibuprofen (3-4 dd, 400 mg), diclofenac (3-4 dd, 25-50 
mg), or naproxen (2-3-dd, 250 mg). 
Referral: Refer in an instant: 1) cauda equina syndrome, or 2) progressive paresis within a few days in spite of 
conservative care. Refer for diagnostics and judgement for indication for surgery: 1) Severe radicular pain in spite 
of bed rest and adequate medication, 2) Severe paresis or progressive paresis in spite of adequate care (walking on 
heels and toes is impossible), 3) doubtful diagnosis, or 4) mild complaints with no improvement after six to eight 
weeks. 
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Chapter 2 
 
Do neurosurgeons subscribe to the guideline lumbosacral radicular syndrome? 
 
Pim A.J. Luijsterburg, Arianne P. Verhagen, Sigrid Braak, Cees J.J. Avezaat, Bart W. Koes. 
Clin Neurol Neurosurg 2004;106:313-7. 
 
 
Abstract 
 
Background This study presents a survey of the opinion of neurosurgeons on the 
multidisciplinary clinical guideline ‘lumbosacral radicular syndrome’. The aim was to 
describe to what extent neurosurgeons in the Netherlands endorse the content of this 
guideline. The guideline was issued in 1996 by the Netherlands Institute of Quality Health 
Care and this is the first attempt to evaluate the implementation of this guideline. 
Methods All active neurosurgeons (n=92) in the Netherlands were invited to complete a 
questionnaire investigating to what extent they agree with the 26 recommendations in the 
guideline ‘lumbosacral radicular syndrome’. The results are represented in frequencies (%) 
in order to express the magnitude of their consent or dissent with the recommendations. 
Results Overall, 75% of the neurosurgeons responded and, of these, 94% agreed (at least 
partially) with the content of the guideline. Of the 26 recommendations in the guideline, 
seven were not fully endorsed by the neurosurgeons. Three of these seven 
recommendations may need revision based on newly published data. 
Conclusion This survey shows that almost all neurosurgeons subscribed (at least partially) to 
the multidisciplinary LRS guideline. Therefore, one important aspect of the implementation 
process has been fulfilled, i.e. acceptance of the content of the guideline. 
 
Introduction 
 
The lumbosacral radicular syndrome (LRS), also known as ‘sciatica’, is a disorder with 
radiating pain in one or more lumbar or sacral dermatomes, and can be accompanied with 
phenomena associated with nerve root tension or neurological deficits.2,4,11,16 LRS is mostly 
caused by a prolapsed disc, but other causes can include spinal or lateral recess stenosis and 
tumours or radiculitis.1,4 The incidence of LRS in the Netherlands is estimated between 
60,000 and 75,000.1 In the Netherlands the neurosurgeon generally performs surgery in 
patients with LRS caused by a prolapsed disc. 
 
A multidisciplinary clinical practice guideline for LRS was issued in 1996 by the 
Netherlands Institute of Quality Health Care.2 This guideline (as far as possible evidence-
based) is a consensus between 12 (para)medical professions involved in the management of 
patients with LRS. The guideline presents 26 recommendations (see Appendix A) which 
serve to guide physicians in their management of patients with LRS. 
 
Clinical guidelines are developed to improve quality of health care and to foster evidence-
based decision making.6-9 But their recommendations must be implemented to achieve the 
desired outcomes. In order to evaluate the implementation of a particular guideline, it is 
important to know whether the profession concerned accepts the content of the guideline.9 
Therefore, this study investigated to what extent neurosurgeons in the Netherlands endorse 
the content of the LRS guideline. 
Materials and methods 
 
In June 2001 a questionnaire about the LRS guideline was mailed to all 92 active 
neurosurgeons associated with the Netherlands Society of Neurosurgeons, together with a 
letter of recommendation from the chairman of the Society. Reminders were sent after 1 
and 2 months. 
 
The questionnaire addressed the following: (1) neurosurgeons’ characteristics including 
age, gender, years of working experience and their type of neurosurgery centre (i.e. 
university/non-university); (2) to what extent they are acquainted with the content of the 
multidisciplinary guideline, with answer options: (almost) entirely, partially, and (almost) 
not; (3) to what extent they subscribe to the content of the guideline, with answer options: 
(almost) entirely, partially, and (almost) not; and (4) to what extent they agree with each of 
the 26 recommendations in the guideline, each recommendation had the answer option: 
(almost) entirely, partially, and (almost) not. All answers could be explained with an 
explanation if required. In addition, because two of the 26 recommendations concern 
general practitioners (GPs) and because GPs have their own LRS guideline11, neurosurgeons 
were also asked about their acquaintance with the GPs’ guideline for LRS. 
 
Descriptive statistics were used to present the frequencies of the neurosurgeons’ 
agreement/disagreement with the multidisciplinary guideline; all frequencies are based on 
the total number of neurosurgeons. All variables used to describe the neurosurgeons’ 
characteristics are presented as the mean and standard deviation (SD) if they are normally 
distributed, and by the median and interquartile range (IQR) if they are not normally 
distributed. We decided that any of the 26 recommendations in the questionnaire was 
debatable when 60% or less of the neurosurgeons did not agree (almost) entirely with a 
particular recommendation. All data were coded and analysed using the statistical package 
SPSS for Windows (version 10.0.7). 
 
Results 
 
Neurosurgeons’ characteristics 
Of the 92 invited neurosurgeons, 69 (75%) returned the questionnaire. Because 3 of the 
responding neurosurgeons stated that they did not treat LRS patients, data from 66 
respondents were included in the analysis. Reasons for non-response are unknown because 
the questionnaires were returned anonymously. The median age of the neurosurgeons was 
45 (IQR 15) years, 9% were female, and the median work experience was 12 (IQR 17) years. 
The neurosurgeons estimated to manage a median of 60 LRS patients (IQR 67) during a 3-
month period. The median number of patients with LRS who underwent surgery was 
estimated to be 30 (IQR 45) patients in a 3-month period. 
 
Subscribing to the LRS guideline 
The neurosurgeons were asked if they were acquainted with the content of the 
multidisciplinary guideline and to what extent they subscribe to the guideline. Table 1 
shows that 91% are acquainted (at least partially) with the content of the guideline, and that 
94% subscribe (at least partially) to the guideline. In contrast, only 50% were acquainted 
with the LRS guideline issued by the Dutch College of General Practitioners. 
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Table 1: Neurosurgeons’ responses to questions about the multidisciplenary LRS guideline and the LRS guideline 
issued by the Dutch College of General Practitioners (GPs’ guideline). 
 
 Neurosurgeons, n (%) 
Acquainted with the content of the guideline: 
(almost) entirely 
partially 
(almost) not at all 
missing answers 
 
42 (63.5) 
18 (27.5) 
6 (9.0) 
0 (0.0) 
Subscribe to the guideline: 
(almost) entirely 
partially 
(almost) not at all 
missing answers 
 
24 (36.5) 
38 (57.5) 
0 (0.0) 
4 (6.0) 
Acquainted with the content of the GPs’ guideline: 
(almost) entirely 
partially 
(almost) not at all 
missing answers 
 
15 (22.5) 
18 (27.5) 
33 (50.0) 
0 (0.0) 
n= number of neurosurgeons. 
 
Recommendations 
Appendix A lists the 26 recommendations in the multidisciplinary LRS guideline. Table 2 
shows to what extent the neurosurgeons agree/disagree with these recommendations. 
Over 60% of the neurosurgeons completely agreed with 19 of the 26 recommendations. The 
remaining 7 recommendations, which were endorsed by less than 60% of the 
neurosurgeons, are discussed here. 
1. Arguments against recommendation 12 (The GP can perform clinical diagnostics and 
treatment in most LRS-patients) were: ‘depends on the seriousness of the complaints 
(n=2)’, ‘expert report by the GP is questionable, knowledge of LRS is often insufficient 
(n=6)’, and ‘GPs’ referral to a specialist is usually late (n=2)’. 
2. Arguments against recommendation 17 (The most important indication for surgery in 
prolapsed disc is severe radicular pain and not the sensory deficits, except for the cauda 
equina syndrome) were: ‘the presence of neurological deficits can be an additional 
reason to perform surgery (n=2)’, and ‘as well as severe suffering an important 
indication for surgery (n=17)’. 
3. Arguments against recommendation 19 (After six weeks the GP should discuss the 
option of surgery with the patient with LRS when there is no clear improvement of the 
complaints) were: ‘six weeks is too long (n=8)’, and ‘depending on the seriousness of the 
complaints and level of neurological deficits surgery must be considered sooner (n=5)’. 
4. Arguments against recommendation 20 (There is no evidence that the prognosis of 
paresis improves by surgical intervention) were: ‘experience has shown that muscle 
strength in the leg does improve after surgery (n=7)’, and ‘has not yet been evaluated, so 
it can be an indication (n=5)’. 
 
 
 
 
Table 2: Neurosurgeons’ (n=66) level of agreement/disagreement (frequencies) with the 26 recommendations in 
the multidisciplinary LRS guideline. 
 
Recommendation: (almost) entirely, % Partially, % (almost) not, % Missing, % 
1 96 1 1 2 
2 82 17 0 1 
3 73 21 5 1 
4 89 9 0 2 
5 73 21 5 1 
6 68 17 11 4 
7 70 20 6 4 
8 64 20 9 7 
9 64 23 9 4 
10 35 41 18 6 
11 71 21 5 3 
12 55 33 12 0 
13 53 32 14 1 
14 82 9 6 3 
15 74 21 2 3 
16 83 14 3 0 
17 41 39 15 5 
18 6 27 59 8 
19 58 32 6 4 
20 55 26 15 4 
21 91 3 2 4 
22 76 14 5 5 
23 79 18 2 1 
24 65 29 6 0 
25 86 14 0 0 
26 65 30 0 5 
 
Finally, the neurosurgeons reported that new evidence was available that no longer 
supported 3 of the recommendations: 
• Recommendation 10 (Neurophysiological examination can provide additional 
information about the location and severity of the nerve root damage, when radiological 
findings are not in accordance with clinical findings) because: ‘the additional 
information from a neurophysiological examination is poor (n=9)’. 
• Recommendation 13 (Conservative treatments are not sufficiently investigated to draw 
conclusions regarding their effectiveness) because: ‘bed rest, traction and psychotherapy 
have been examined and are demonstrated not to be useful (n=16)’. 
• Recommendation 18 (chemonucleolysis is proven effective for LRS caused by prolapsed 
disc; the results after one year correspond with the results of surgery) because: 
‘indication is limited, chemonucleolysis is not effective (n=8)’, ‘percentage of patients 
with complaints after chemonucleolysis is higher than after surgery (n=6)’, and 
‘chemonucleolysis is effective but less effective than surgery (n=3)’.  
 
Indication for and timing of surgery 
The questionnaire asked the neurosurgeons: “What, in your opinion, is the indication for 
surgery in patients with LRS caused by a prolapsed disc?” 
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The neurosurgeons reported 8 indications: the cauda equina syndrome (68%), long-term 
and disabling pain (67%), progressive paresis (33%), radiological findings in accordance 
with clinical signs (15%), patients’ wishes (15%), recurrences (11%), acute paresis (9%), and 
persisting complaints (6%). 
 
They were also asked: “At what point of time after the onset of an LRS episode do you 
recommend surgery for a patient with LRS caused by a prolapsed disc with pain and no 
neurological deficits?” Table 3 gives the neurosurgeons’ answers (range 2-16 weeks) to this 
question. 
 
Table 3: Neurosurgeons (n=66) recommended timing of surgery for patients with LRS caused by a prolapsed disc. 
 
Surgery after: %* 
2 to 6 weeks 17 
6 weeks 18 
6 to 8 weeks 5 
8 weeks 14 
8 to 12 weeks 9 
12 weeks 15 
12 to 16 weeks 6 
*  Missing values 16%. 
 
About half of the neurosurgeons (54%) preferred to wait 2-8 weeks and the remainder 
preferred to wait 8-16 weeks before performing surgery. 
 
Discussion 
 
An important condition for the implementation of any guideline is the extent to which a 
profession agrees with the content of the guideline.9,20 This survey shows that most (94%) of 
the participating neurosurgeons agrees (at least partially) with the content of the 
multidisciplinary guideline for the management of LRS. The neurosurgeons endorsed 19 of 
the 26 recommendations in the guideline; the remaining 7 recommendations were accepted 
by less than 60% of the neurosurgeons. Recommendations 17, 19 and 20 are still being 
debated because there are (as yet) no convincing data available. Due to a difference in 
viewpoint between neurosurgeons and GPs, less than 60% of the neurosurgeons agreed with 
recommendation 12 (The GP can perform clinical diagnostics and treatment in most LRS 
patients). This difference may be due to the fact that 50% of the neurosurgeons were not 
aware of the content of the LRS guideline issued by the Dutch College of General 
Practitioners. For recommendations 10, 13 and 18 the neurosurgeons reported that new 
evidence invalidated these three recommendations. 
 
In spite of the high response (75%) to the questionnaire some selection bias may have 
occurred. For example, because the questionnaire was returned anonymously, we have no 
way of determining the reasons for non-response. Although it is possible that our results 
under- or overestimate acceptance of the guideline by neurosurgeons, we cannot confirm 
this. 
 
Because the questionnaire was specifically developed for this study based on the content of 
the LRS guideline, no data on the reliability and validity of this questionnaire are available. 
Also we arbitrarily selected a cut-off point of 60% or less as a measure of whether or not a 
recommendation was endorsed. 
 
In the Netherlands, patients with the lumbosacral radicular syndrome are not only operated 
by neurosurgeons. Also orthopedic surgeons perform this operation, but only in a minority 
of patients (17%). The results of this study cannot be generalized towards the orthopedic 
surgeons in the Netherlands. 
 
The timing of sugery for a patient with LRS caused by a prolapsed disc ranged from 2 to 16 
weeks (Table 3). Half of the neurosurgeons preferred to wait less than 8 weeks, and the 
others preferred to wait more than 8 weeks. Recommendation 16 of the guideline indicates 
a waiting period of 4 to 8 weeks. 
The LRS guideline of the Dutch College of General Practitioners recommends referral to a 
specialist when there is no improvement after 6 to 8 weeks. The literature provides no 
evidence for the most optimal timing of surgery. 
 
The adherence towards the guideline LRS in neurosurgeons’ daily practice was not 
evaluated in this study. In the Netherlands, we do not know to what extent the 
neurosurgeons actually follow the recommendations of the guideline LRS. Here we only 
evaluated their altitude towards the guideline because without a positive attitude, 
implementation becomes difficult. 
 
Conclusion 
 
This study shows that neurosurgeons largely subscribe to the guideline for the management 
of LRS. The next important step is to investigate the neurosurgeons’ actual management of 
LRS patients compared with the guideline recommendations. Nevertheless, guidelines need 
to be regulary updated to remain useful to clinicians. The multidisciplinary clinical 
guideline for the management of LRS was issued in 1996. The present study, 6 years later, 
shows that neurosurgeons consider that 3 recommendations need to be updated based on 
new evidence. Shelleke et al. estimated that guidelines should be reassessed for validity 
every 3 years.21 Therefore, more studies are needed on the management of LRS in order to 
update the guidelines for this syndrome. 
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Appendix A: Recommendations in the multidisciplinary clinical guideline for the management of LRS. 
 
1. LRS is characterised by radiating pain in one or more lumbo or sacral dermatomes, with or without other radicular 
symptoms. 
2. LRS is often caused by a prolapsed disc, but is also caused by a spinal or resessus stenosis, or a combination of 
these. 
3. LRS cannot be explained by mechanical compression of a nerve root only. 
4. Many radiological abnormalities in the lumbar spine are not associated with nerve root compression or pain. 
5. The test of Lasègue is the most valid and reliable test in acute LRS due to prolapsed disc. The test of Lasègue is 
often negative in neurological claudicatio. 
6. There is no indication for routine X-rays of the lumbar spine in acute LRS. 
7. MRI or CT-scan is only needed when surgery is considered, or if the results could have other therapeutical 
consequences. 
8. MRI and CT-scan both have a high sensitivity for detecting a prolapsed disc and a low specificity: it is often 
impossible to distinguish between a prolapsed disc that causes the LRS and an accidental finding on the basis of 
imaging alone. 
9. In radiological imaging of LRS, MRI is preferred; CT-scan is a good alternative. If uncertainty of nerve root 
compression persists caudography is indicated. 
10. Neurophysiological examination can provide additional information about the location and severity of the nerve 
root damage, when radiological findings are not in accordance with clinical findings. 
11. LRS is often self-limiting. The results of conservative treatments and surgery are similar in the long term (4-10 
years), i.e. for those patients who do not undergo surgery because of progressive paresis or cauda equina syndrome. 
12. The GP can perform clinical diagnostics and treatment in most LRS patients. Referral to a specialist is only useful 
when the GP is not sure about the diagnosis or considers surgical intervention. 
13. Conservative treatments (e.g. bed rest, traction, physiotherapy and manipulation) are not sufficiently investigated 
to draw conclusions regarding their effectiveness. 
14. The statement that strict bed rest (toilet visits and showering not permitted) is more effective in LRS due to 
prolapsed disc than liberal bed rest (toilet visits and showering permitted) is not based on prospective RCTs. 
15. Effectiveness of ‘back-schools’ for LRS has not yet been investigated, neither for treatment, nor for prevention. 
16. A severe LRS, persisting for 4 to 8 weeks with no improvement, is an indication for radiological examination 
possibly followed by surgical intervention. If there is improvement, a longer ‘wait and see’ policy is possible. 
17. The most important indication for surgery in prolapsed disc is severe radicular pain and not the sensory deficits, 
except for the cauda equina syndrome. 
18. Chemonucleolysis is proven effective for LRS caused by a prolapsed disc; the results after one year correspond 
with the results of surgery. 
19. After 6 weeks the GP should discuss the option of surgery with the LRS patient when there is no clear 
improvement of the complaints. 
20. There is no evidence that the prognosis of paresis improves by surgical intervention. Therefore, a light or 
moderate paresis is not an absolute indication for surgery. 
21. Cauda equina syndrome caused by lumbar disc prolapse is an absolute indication for rapid surgery. 
22. Percutaneous nucleotomy and percutaneous laser therapy are not evidenced-based treatments for LRS caused by 
disc prolapse. 
23. There are no proven effective programs of treatment for primary or secondary prevention of LRS. 
24. Advice not to work during and after the treatment of LRS, even in demanding jobs, should be given cautiously. 
This could delay rehabilitation. 
25. The treating surgeon is responsible for medical care before and after surgery. 
26. There are strong indications that psychological, social and financial factors play an important role in the 
development of persisting LRS (and the related disability). 
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Chapter 3 
 
Neurosurgeons’ management of lumbosacral radicular syndrome evaluated against a 
clinical guideline 
 
Pim A.J. Luijsterburg, Arianne P. Verhagen, Sigrid Braak, Anushka Oemraw, Cees J.J. 
Avezaat, Bart W. Koes. 
Eur Spine J 2004;13:719-23. 
 
 
Abstract 
 
Objectives To establish to what extent neurosurgeons subscribe to the lumbosacral radicular 
Syndrome (LRS) guideline, and to evaluate their current management of patients with LRS 
against the guideline. 
Methods All active neurosurgeons in the Netherlands (n=92) were mailed a questionnaire 
about the guideline and data from 66 responders were analysed. Patients were recruited via 
seven of the participating neurosurgeons and were interviewed once by telephone. The 
medical records of the participating patients (n=163) were also examined. 
Results Of the 26 propositions in the LRS guideline, seven are not fully endorsed by the 
neurosurgeons. Three of these seven propositions may need updating based on ‘new 
evidence’. The time between the onset of the LRS episode and the actual moment of surgery 
was considerably longer than that recommended in the guideline. 
Conclusions Based on their current management of LRS patients, the neurosurgeons largely 
adhere with the LRS guideline. 
 
Introduction 
 
The use of clinical practice guidelines in health care has grown rapidly and is now 
widespread.13 Guidelines can be seen as a tool to improve the quality of health services and 
to incorporate latest scientific knowledge into daily clinical routines,6,7 their 
implementation has been shown to improve clinical practice.8-10 Rates of adherence with 
guidelines are extremely variable, ranging from 20% to nearly 100%, depending on the 
guideline and definition of adherence.8,14,15 
 
A clinical practice guideline for the lumbosacral radicular syndrome (LRS) was issued in 
1996 by the Dutch Institute of Quality Health Care.2 This LRS guideline is a consensus 
between 12 (para)medical specialties (physical therapists, general practitioners, 
orthopedists, anesthetists, epidemiologists, neurosurgeons, neurophysiologists, 
neurologists, radiologists, rehabilitation doctors, physical medical sciences, social medical 
sciences) involved in treating patients with LRS. The guideline presents 26 propositions that 
(as far as possible) have been evidence-based (see Appendix A). These propositions serve to 
guide physicians in the management of patients with LRS. 
 
The LRS, also called sciatica, is a disorder with radiating pain in one or more lumbar or 
sacral dermatomes, and can be accompanied with phenomena associated with nerve root 
tension or neurological deficits.2,4,11,16 LRS is mostly caused a prolapsed disc but other causes 
include spinal or lateral recess stenosis, tumours, or infections.1,2,4,11 
 
Patients with LRS usually visit their general practitioner (GP) first, and most are treated by 
their GP. According to the GPs’ own guideline for LRS surgery can be recommended for 
patients with objective evidence of a prolapsed disc who have not responded to conservative 
treatment.11,12 If this is the case, the patient is usually referred to a neurologist or a 
neurosurgeon. In the Netherlands the neurosurgeon generally performs surgery in those 
patients with LRS caused by a prolapsed disc. In the Netherlands, no data are available 
about the adherence of neurosurgeons with the LRS guideline, or on their current 
management of patients with LRS.1 
Therefore, the aim of this study is to evaluate the implementation of the LRS guideline by 
neurosurgeons by exploring to what extent neurosurgeons endorse the content of the 
guideline, and by evaluating their current management of LRS patients who had undergone 
surgery because of a prolapsed disc in the lumbar spine, against the guideline. 
 
Materials and methods 
 
Neurosurgeons 
All 92 neurosurgeons active in the Netherlands, and associated with the Dutch Society of 
Neurosurgeons, were invited to participate in this study in June 2001. 
 
Patients 
Patients were recruited from the practices of seven of the participating neurosurgeons 
working in four different hospitals in the southern part of the Netherlands. Invited to 
participate in the study were consecutive LRS patients who had undergone surgery because 
of a prolapsed disc in the lumbar spine in the previous six months. Additional inclusion 
criteria were: age between 18 and 65 years, approachable by telephone, understanding 
Dutch, and providing written informed consent. Excluded were patients with a prolapsed 
disc other than at the L4-L5, and L5-S1 levels. Eligible patients gave their written informed 
consent before they enter in the study. 
 
Neurosurgeons’ questionnaire 
A questionnaire about the LRS guideline (i.e. asking about neurosurgeons’ management of 
LRS patients in general) was mailed to the neurosurgeons together with by a letter of 
recommendation from the chairman of the Dutch Society of Neurosurgeons. This 
questionnaire (to be returned anonymously) contained questions on (1) neurosurgeons’ 
characteristics including age, gender, years of working experience, and their type of 
neurosurgical center (i.e. university or non-university), (2) to what extent they endorse to 
the content of the guideline ‘in general’, with answer options: (almost) entirely, partially, 
and (almost) not, and (3) to what extent they agree with each of the 26 concrete 
propositions in the guideline (see Appendix A), with for each proposition the answer 
options: (almost) entirely, partially, and (almost) not. For each question, respondents could 
give additional information/explanation as required. 
 
Patients’ interview 
When written consent was received from the patient, a telephone interview was conducted 
to establish: 1) patients’ characteristics including age, gender, and 2) complaint 
characteristics at the first consultation with the neurosurgeon, e.g. duration, location, 
urinary problems, saddle anaesthesia, and influence of rest, specific body position, 
movement and of coughing/sneezing/straining. 
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Finally, we searched in the medical record of each patient to establish to what extent 
(compared with the guideline) the neurosurgeons had reported the complaint 
characteristics, carried out physical, radiological and neurophysiological examinations, and 
reported the indication for surgery. 
 
Statistical analysis 
Descriptive statistics were used to present the frequencies of neurosurgeons subscribing to 
the content of the guideline and their adherence with the guideline. All frequencies are 
based on the total number participating neurosurgeons or patients. All variables used to 
describe the neurosurgeons’ and patients’ characteristics are presented as the mean and 
standard deviation (SD) if they are normally distributed, and as median and interquartile 
range (IQR) if they are not normally distributed. 
 
We determined that a proposition was accepted when 60% or more of the neurosurgeons 
gave the answer option: ‘(almost) entirely’ for a particular proposition. After careful 
consideration with experts (general practitioners, neurosurgeons, epidemiologists) we 
decided that the adherence towards the guideline should be evaluated against 6 main 
recommendations from the guideline. We expected, in accordance with the main 
recommendations that: 
1. the straight leg raising test and an MRI or CT-scan would be performed in all patients; 
2. X-rays would not routinely be made; 
3. neurophysiological examinations would not be performed in all patients (because they 
offer little additive information); 
4. the indication for surgery would be reported in the medical record of all patients; 
5. surgery would take place 4-8 weeks after the onset of the LRS episode; 
6. the neurosurgeons would follow up patients after surgery. 
 
If 5 or 6 of these main recommendations were followed then the neurosurgeons adherence 
with the guideline was considered good, adherence was considered moderate when 3 or 4 
recommendations were followed, and weak when only 1 or 2 were followed. 
The data were coded and analysed using the statistical package SPSS for Windows (release 
10.0.7). 
 
Ethics 
The procedures of this study were in accordance with the ethical standards of the revised 
Helsinki declaration of 1983 and were approved by the Erasmus Medical Center ethics 
committee. 
 
Results 
 
Neurosurgeons’ characteristics 
Of the 92 invited neurosurgeons, 69 (75%) returned the questionnaire. Because three of 
these respondents reported that they did not treat patients with LRS, data from 66 
neurosurgeons were included in the analysis. Reasons for non-response are unknown 
because the questionnaires were returned anonymously. The median age of the 66 
participating neurosurgeons was 45 (IQR 15) years, 9% were female, and the median work 
experience was 12 (IQR 17) years. Of the total group, 33% worked in a university 
neurosurgery center, 35% in a non-university center, and 32% worked in both a university 
and non-university neurosurgery center. 
Endorsement of the LRS guideline? 
A total of 37% of the neurosurgeons subscribed entirely to the content of the guideline, 57% 
subscribed partially and 6% had missing values. Of the 26 propositions in the guideline (see 
Appendix A), propositions 10, 12, 13, 17-20 were subject to debate. According to the 
neurosurgeons, 3 of these 7 (i.e. 10, 13 and 18) may need updating. These three 
propositions concern 1) the additive value of the neurophysiologic examination (EMG), 2) 
the effectiveness of conservative treatments, and 3) the effectiveness of chemonucleolysis. 
 
Patients’ characteristics 
In the period October 2001 to January 2002, we invited 250 patients (selected from the 
practices of seven of the neurosurgeons) to participate in this study. These seven 
neurosurgeons did not differ from the other neurosurgeons in the Netherlands, except that 
they were all male (in Dutch neurosurgeons 10% is woman). We received written informed 
consent from 163 patients. Table 1 lists the complaints characteristics of the participating 
patients at their first consultation with the neurosurgeon, as recalled and reported during 
the telephone interview. 
 
Table 1: Complaints of the patients (n=163) at the first consultation with the neurosurgeon and recalled during the 
telephone interview for this study. 
 
 n (%) 
Back pain with irradiating pain into the leg 140 (86) 
Pain below the knee 158 (97) 
Sensory deficits in the leg 142 (87) 
Decreased muscle strength in the leg 134 (82) 
Less pain on rest 58 (36) 
More pain on daily activities 107 (66) 
Specific body position with more or less pain 125 (77) 
More pain on coughing, sneezing or straining 112 (69) 
Presence of urinary problems 44 (27) 
Presence of saddle anaesthesia 88 (54) 
n= number (and percentage) of patients. 
 
The mean age of the participating patients was 44 (SD 10) years and 86 patients (53%) were 
female. Telephone interviews were held with all 163 patients on average of 26 (SD 10) weeks 
after surgery. The median length of time between the onset of the LRS complaints and the 
consultation with their GP was 4 (IQR 24) weeks, whereas 17 (IQR 26) weeks elapsed 
between the first consultation with the neurosurgeon. The median length of time between 
the first consultation with the neurosurgeon and surgery was 6 (IQR 9) weeks. 
 
Management of LRS patients 
Of the initial 163 patients, we were able to trace the medical records of 156 (62%) persons. 
Table 2 gives the examinations in the medical records that were ordered by the 
neurosurgeons in these 156 patients. 
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Table 2: Examinations in the medical records as ordered by the neurosurgeons in 156 of the participating patients. 
 
 n (%) 
Physical examinations:  
Physical inspection 
Active examination 
Straight leg raising test 
Test of Bragard 
Crossed straight leg raising test 
Ankle tendon reflex 
Knee tendon reflex 
Sensory deficits of the foot 
Strength of the big toe 
Walking on heels and on toes 
55 (35) 
61 (39) 
103 (66) 
18 (12) 
10 (6) 
74 (47) 
61 (39) 
79 (51) 
26 (17) 
27 (17) 
Radiological and neurophysiological examinations:  
X-rays 
Computed tomography 
Magnetic resonance imaging (MRI) 
Electromyography (EMG) 
12 (8) 
51 (33) 
96 (62) 
4 (3) 
n= number (and percentage) of patients. 
 
With the exception of the straight leg raising test and tests for sensory deficits in the foot, 
all other physical examinations were performed in less than 50% of the patients. 
Radiological examination (MRI or CT-scan) was performed in almost all patients. 
According to the medical records, X-rays were rarely made, and EMGs were seldom 
performed. 
 
The indication for surgery was reported in the medical records of all patients i.e. 1) a 
prolapsed disc L4-L5 (31%), 2) a prolapsed disc L5-S1 (37%), 3) a prolapsed disc L4-L5 and 
L5-S1 (5%), 4) a persisting lumbosacral syndrome (21%), and 5) other indications (6%). 
 
Based on the medical records, the median length of time between the onset of the LRS 
episode and the first consultation with the neurosurgeon was 24 (IQR 24) weeks. The 
median length of time between the first consultation with the neurosurgeon and surgery 
was 5 (IQR 7.5) weeks. Thus, the actual length of time between the onset of the LRS episode 
and the moment of surgery was considerably longer than recommended in the guideline 
(i.e. 29 weeks versus 4-8 weeks in the guideline) due to the medical system in the 
Netherlands. According to the medical records, the neurosurgeons followed-up 76% of the 
patients after surgery only once. 
Overall, the neurosurgeons deviated from only one of the six main recommendations (i.e. 
time to surgery after the of the LRS episode). Therefore, we consider the neurosurgeons’ 
adherence with the guideline to be good. 
 
Discussion 
 
Most of the neurosurgeons (94%) agreed (at least partially) with the content of the 
multidisciplinary LRS guideline. 
They did not fully endorse 7 of the 26 propositions in the guideline. Three of these 7 
propositions may need updating based on ‘new evidence’, i.e. 1) the additive value of the 
neurophysiologic examination (EMG), 2) the effectiveness of conservative treatments, and 
3) the effectiveness of chemonucleolysis. 
According to their current management of LRS patients, neurosurgeons’ adherence with 
the guideline is good. However, the length of time between the onset of the LRS episode and 
the moment of surgery was considerably longer than that recommended in the guideline. 
Some limitations of this study need to be discussed. 
In spite of the high response rate (75%) to the questionnaire, selection bias may have 
occurred. About 25% of the neurosurgeons working in the Netherlands did not respond, 
but because of the anonymity we cannot establish the reasons for non-response. The results 
of this study may under- or overestimate endorsement of the guideline by neurosurgeons, 
but it is not possible to confirm this. 
There were 87 patients (35%) who did not participated in the study. Unfortunately, we 
could not collect any data from these non respondents. Therefore, we do not know if there 
was a selective non response or not. The participating LRS patients were invited because of 
surgery on the basis of a prolapsed disc in the lumbar spine. Patients with LRS caused by a 
tumour, stenosis or infection were not included in this study, therefore we cannot easily 
generalize the results of our study to these LRS patients. 
 
Because the questionnaires were specifically developed for this study (based on the LRS 
guideline), no data are available on the reliability and validity of these questionnaires. Also, 
we arbitrarily determined a plausible cut-off point of 60% for acceptance of the propositions 
in the guideline. 
 
We found some differences in history characteristics, radiological and neurophysiological 
examinations between details reported in the interviews with the patients and those 
reported in the medical records by the neurosurgeons. 
Other studies have reported similar discrepancies.22 These discrepancies might be due to 
over-reporting by the patients due to recall bias, or under-reporting by the neurosurgeons 
due to incomplete registration in the medical records. 
Recall bias could occur in the patients, because the interviews took place on average of 26 
(SD 10) weeks after surgery. Because some items/values in the medical records were 
missing, the actual adherence with the guideline might be better if all data had been 
completed. 
 
All patients were recruited from the practices of seven of the participating neurosurgeons 
working in four different hospitals in the southern part of the Netherlands. Based on their 
management of the LRS patients, their adherence with the guideline is good. These results 
cannot be generalised to all neurosurgeons in the Netherlands. Another study is needed in 
which more patients are recruited from different neurosurgical centers throughout the 
Netherlands. 
 
This study shows that the participating neurosurgeons largely subscribe to the 
multidisciplinary LRS guideline, which is an important condition for the implementation of 
the guideline. The results also show that the neurosurgeons largely adhered with the 
guideline in their current management of LRS patients. Future studies to evaluate 
nationwide implementation of the guideline should recruit patients from different types of 
neurosurgical centres throughout the Netherlands using a prospective design. 
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Appendix A: Propositions in the multidisciplinary clinical guideline for the management of LRS. 
 
1. LRS is characterised by radiating pain in one or more lumbo or sacral dermatomes, with or without other radicular 
symptoms. 
2. LRS is often caused by a prolapsed disc, but is also caused by a spinal or resessus stenosis, or a combination of 
these. 
3. LRS cannot be explained by mechanical compression of a nerve root only. 
4. Many radiological abnormalities in the lumbar spine are not associated with nerve root compression or pain. 
5. The test of Lasègue is the most valid and reliable test in acute LRS due to prolapsed disc. The test of Lasègue is 
often negative in neurological claudicatio. 
6. There is no indication for routine X-rays of the lumbar spine in acute LRS. 
7. MRI or CT-scan is only needed when surgery is considered, or if the results could have other therapeutical 
consequences. 
8. MRI and CT-scan both have a high sensitivity for detecting a prolapsed disc and a low specificity: it is often 
impossible to distinguish between a prolapsed disc that causes the LRS and an accidental finding on the basis of 
imaging alone. 
9. In radiological imaging of LRS, MRI is preferred; CT-scan is a good alternative. If uncertainty of nerve root 
compression persists caudography is indicated. 
10. Neurophysiological examination can provide additional information about the location and severity of the nerve 
root damage, when radiological findings are not in accordance with clinical findings. 
11. LRS is often self-limiting. The results of conservative treatments and surgery are similar in the long term (4-10 
years), i.e. for those patients who do not undergo surgery because of progressive paresis or cauda equina syndrome. 
12. The GP can perform clinical diagnostics and treatment in most LRS patients. Referral to a specialist is only useful 
when the GP is not sure about the diagnosis or considers surgical intervention. 
13. Conservative treatments (e.g. bed rest, traction, physiotherapy and manipulation) are not sufficiently investigated 
to draw conclusions regarding their effectiveness. 
14. The statement that strict bed rest (toilet visits and showering not permitted) is more effective in LRS due to 
prolapsed disc than liberal bed rest (toilet visits and showering permitted) is not based on prospective RCTs. 
15. Effectiveness of ‘back-schools’ for LRS has not yet been investigated, neither for treatment, nor for prevention. 
16. A severe LRS, persisting for 4 to 8 weeks with no improvement, is an indication for radiological examination 
possibly followed by surgical intervention. If there is improvement, a longer ‘wait and see’ policy is possible. 
17. The most important indication for surgery in prolapsed disc is severe radicular pain and not the sensory deficits, 
except for the cauda equina syndrome. 
18. Chemonucleolysis is proven effective for LRS caused by a prolapsed disc; the results after one year correspond 
with the results of surgery. 
19. After 6 weeks the GP should discuss the option of surgery with the LRS patient when there is no clear 
improvement of the complaints. 
20. There is no evidence that the prognosis of paresis improves by surgical intervention. Therefore, a light or 
moderate paresis is not an absolute indication for surgery. 
21. Cauda equina syndrome caused by lumbar disc prolapse is an absolute indication for rapid surgery. 
22. Percutaneous nucleotomy and percutaneous laser therapy are not evidenced-based treatments for LRS caused by 
disc prolapse. 
23. There are no proven effective programs of treatment for primary or secondary prevention of LRS. 
24. Advice not to work during and after the treatment of LRS, even in demanding jobs, should be given cautiously. 
This could delay rehabilitation. 
25. The treating surgeon is responsible for medical care before and after surgery. 
26. There are strong indications that psychological, social and financial factors play an important role in the 
development of persisting LRS (and the related disability). 
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Chapter 4 
 
High level of satisfaction among patients despite persistent symptoms in the mid-long-
term following surgery for the lumbosacral radicular syndrome 
 
Pim A.J. Luijsterburg, Arianne P. Verhagen, Hilde.K. Schreuder, Cees J.J. Avezaat, Bart W. 
Koes. 
Ned Tijdschr Geneeskd 2005;149:1516-20 (in Dutch) 
 
 
Abstract 
 
Objective To determine the mid-long-term outcomes (complaints/treatment satisfaction) 
after surgery in patients with lumbosacral radicular syndrome (LRS) and to identify 
prognostic factors for persisting LRS symptoms. 
Design Descriptive retrospective and prospective study. 
Method A total of 250 consecutive patients operated by seven neurosurgeons in four 
hospitals between May and December 2001 were selected from the medical records. 
Patients were invited to participate in a telephone questionnaire at 6 and 19 months post-
surgery. All patients had undergone discectomy for LRS (at L4-L4 or L5-S1) and all were 
aged between 18 and 65 years. 
Results Of the 250 patients, 163 participated in the study: of these, 63% reported that LRS-
related complaints persisted 19 months after surgery. However, compared with pre-surgery, 
severe leg pain had decreased in 83% of the patients. Most patients were satisfied with their 
treatment. Female gender and an age of 51-65 years appeared to be prognostic factors for 
persistent LRS symptoms. 
Conclusion More than half of the patients reported LRS complaints 19 months after surgery. 
 
Introduction 
 
The lumbosacral radicular syndrome (LRS) is a frequently seen disorder in the Netherlands 
with an annual incidence of 5 per 1000 patients (i.e. 60,000-75,000 new patients with LRS 
each year).1 Hoogendoorn et al.23 reported that there are about 10,000 operations due to 
LRS caused by a prolapsed disc each year in the Netherlands; this is 6 times more than in 
Scotland, 4 times more than in England, and twice as many as reported in Sweden.24 
 
To our knowledge only one randomised trial has evaluated the effectiveness of surgery 
compared to conservative treatment in 126 patients with a prolapsed disc.25 At 1-year 
follow-up there was a significant difference between the two groups in favor of surgery, 
whereas at 4 years and at 10 years follow-up no significant differences were found between 
the groups.25 
 
In addition, some descriptive studies have reported on operated patients.26-37 The wide 
range in the reported rate of ‘successful’ surgery (i.e. from 40% to 90%) is probably due to 
differences in study design, outcome measures and follow-up periods. However, it remains 
unclear which factors (such as, for example, age, gender and weight) are indeed prognostic 
for persisting LRS complaints after surgery.25,38-43 
 
Therefore, this study investigated the course of complaints after surgery in patients with 
LRS due to a prolapsed disc (at level L4-L5 or L5-S1), and the prognostic factors for 
persisting LRS complaints. 
 
Methods 
 
Design 
This was a descriptive retrospective and prospective study in patients with LRS who 
underwent surgery. 
 
Patients 
The study population consisted of 250 consecutive patients whose data were supplied by 
seven neurosurgeons from four Dutch hospitals (in the provinces of Zuid-Holland, Zeeland 
and Noord-Brabant). These patients were selected from the electronic medical files in the 
period May through December 2001. All patients with LRS had undergone surgery due to a 
prolapsed disc at level L4-L5 or L5-S1, and were aged between 18 and 65 years. These 250 
patients were invited by post to participate in the present study. After acceptance they were 
contacted by telephone to answer a questionnaire at 6 months and 19 months post-surgery. 
 
Questionnaires 
In the first questionnaire (at 6 months follow-up) patients were asked about demographic 
and clinical variables that could influence the course of LRS complaints, e.g. gender, age, 
height, bodyweight, suffering from diabetes, education level, type of employment, sports 
activities, smoking behaviour, time between first visit to the neurosurgeon and surgery, 
severity of pain in the leg, and sensory deficits and/or decreased muscle strength in the leg 
before surgery. 
At 19 months follow-up patients were asked about severity of pain in the leg, and about 
sensory deficits and/or decreased muscle strength in the leg at the moment of the telephone 
call. Answers to these questions were scored by the patient on an 11-point numerical rating 
scale (0 = no pain/no sensory deficits/no decreased muscle strength, to 10 = unbearable 
pain/ total disturbed sensory/total decreased muscle strength). In addition, the patients’ 
level of satisfaction with the treatment was also scored on an 11-point numerical rating 
scale (0 = absolutely not satisfied, to 10 = totally satisfied). 
 
Data Analysis 
A patient was considered free of LRS complaints when reporting no pain in the leg, no 
sensory deficits and no decreased muscle strength. Reported pain in the back was not 
considered to be an LRS complaint. LRS complaints were considered ‘severe’ when patients 
scored 7 or higher on the 11-point rating scale, ‘moderate’ when scored 4-6, and ‘mild’ 
when scored 1 to 3. All data were coded and analysed using SPSS for Windows (version 
11.0.1). Potential prognostic factors during follow-up were identified using univariate 
logistic regression (method: Enter, p-value <0.10). The combination of these prognostic 
factors was tested in a multivariate logistic analysis (method: ‘forward stepwise’ by Wald). 
 
Results 
 
Patients 
Of the 250 patients eligible to join the study, 163 completed the informed consent 
procedure. 
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The first measurement took place at (mean) 6 months (SD 2.5) after surgery in these 163 
patients. In the second measurement at (mean) 19 months (SD 2.1) after surgery, 157 
patients (96%) participated; 1 patient no longer wished to participate and 5 patients could 
not be traced. Table 1 presents the characteristics of the 163 participating patients. 
 
Table 1: Characteristics of the 163 operated patients. 
 
Female (%) 86 (53) 
Mean age in years (SD) 44 (10) 
18-40 years (%) 63 (39) 
41-50 years (%) 49 (30) 
51-65 years (%) 51 (31) 
Mean height in cm (SD) 176 (10) 
Mean bodyweight in kg (SD) 80 (16) 
Time between first visit to neurosurgeon and surgery in weeks (IQR) 6 (9) 
Severe pain in the leg before surgery (%) 158 (97) 
Severe sensory deficits in the leg before surgery (%) 142 (87) 
Severe decreased muscle strength in the leg before surgery (%) 134 (82) 
Severe back pain before surgery (%) 140 (86) 
Paid work before surgery (%) 133 (82) 
Low education level (%) 69 (42) 
Active on sports (%) 153 (94) 
Smoker (%) 98 (60) 
Diabetic (%) 2 (1) 
SD: standard deviation, IQR: interquartile range. 
 
Over half of the patients were female (n=86) and the mean age was 44 (SD 10) years. 
 
Follow-up 
At 19 months follow-up, 58 patients (37%) reported that they were free of LRS complaints 
and 99 patients (63%) still had LRS complaints. Table 2 presents patients’ reported severity 
of complaints at 19 months follow-up. 
 
Table 2: Severity of complaints reported by 157 patients at 19 months follow-up. 
 
Complaint Number of patients (%) 
Severe pain in the leg (%) 26 (17) 
Moderate pain in the leg (%) 37 (24) 
Mild pain in the leg (%) 22 (14) 
No pain in the leg (%) 72 (45) 
Severe sensory deficits (%) 24 (15) 
Moderate sensory deficits (%) 31 (20) 
Mild sensory deficits (%) 14 (9) 
No sensory deficits (%) 88 (56) 
Severe decreased muscle strength (%) 13 (8) 
Moderate decreased muscle strength (%) 26 (17) 
Mild decreased muscle strength (%) 8 (5) 
No decreased muscle strength (%) 110 (70) 
 
Compared with pre-surgery, at 19 months follow-up severe pain in the leg, severe sensory 
deficits and severe decreased muscle strength had decreased by 80%, 72% and 74%, 
respectively. During the 19 months follow-up a second operation was required in 21 and a 
third operation was required in 4 of the 157 patients. Furthermore, 44% of the patients 
reported that they worked less compared with pre-surgery and 61% reported less sports 
activities. A median of 8.0 (IQR 3.0) was scored on patients’ satisfaction with treatment. 
Figure 1 shows the frequency of patient satisfaction; 87% of the patients scored >5 on the 
11-point rating scale. 
 
Figure 1: Patients’ satisfaction (n=157) at 19 months post-surgery: score range 0 (=totally not satisfied) tot 10 
(=very satisfied). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Prognostic factors 
Because gender was a confounder for height and bodyweight, the logistic analyses were 
adjusted for gender. Table 3 gives the prognostic factors for persisting LRS complaints at 19 
months post-surgery. 
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Table 3: Characteristics of the 157 patients with the risk of persisting complaints at 19 months follow-up 
(univariate logistic analysis). 
 
Characteristic No 
complaints 
(n=58) 
Complaints 
(n=99) 
Odds ratio 
(95% CI) 
P 
Women versus men 23 60 2.3 (1.2; 4.5) 0.01$ 
Age 18-40 years versus other 29 31 0.5 (0.2; 0.9) 0.21 
Age 41-50 years versus other 17 30 1.0 (0.5; 2.1) 0.89 
Age 51-65 years versus other 12 38 2.4 (1.1; 5.1) 0.02$ 
Height =< 176 cm versus higher& 26 61 1.3 (0.8; 4.7) 0.54 
Bodyweight =<80 kg versus heavier& 27 62 1.4 (0.7; 3.0) 0.34 
Time between neurosurgeon and surgery 0-7 days versus other 33 57 1.0 (0.5; 2.0) 0.96 
Time between neurosurgeon and surgery 8-14 days versus other 14 20 0.8 (0.4; 1.7) 0.55 
Time between neurosurgeon and surgery 15-30 days versus other 7 12 1.0 (0.4; 2.7) 1.00 
Time between neurosurgeon and surgery > 30 days versus other 2 7 2.1 (0.4; 10.6) 0.36 
Severe pain in leg before surgery versus other * 55 90 1.8 (0.5; 7.1) 0.38 
Severe sensory deficits before surgery versus other * 29 65 0.5 (0.3; 1.0) 0.55 
Severe decreased muscle strength before surgery versus other * 29 46 1.1 (0.6; 2.2) 0.67 
Severe back pain before surgery versus other ** 37 75 1.7 (0.9; 3.6) 0.11 
Low education level versus higher level 28 41 0.8 (0.4-; 1.5) 0.40 
Paid work before surgery versus no paid work 50 83 0.8 (0.3; 2.1) 0.69 
No jogging or running before surgery versus other 50 95 3.8 (1.1; 13.2) 0.04$ 
Smoker before surgery versus no smoker 34 64 1.3 (0.7; 2.5) 0.45 
CI Confidence interval 
$ Significant odds ratio. 
& Adjusted for gender. 
* Patients could have reported more than one LRS-related complaint. 
** Not considered to be an LRS-related complaint. 
 
Three factors from the univariate logistic analysis had a p-value <0.10. The multivariate 
logistic analyses showed that female gender (odds ratio; OR 2.3; 95% CI: 1.2; 4.5) and an age 
of 51-65 years (OR 2.4; 95% CI: 1.1; 5.1) were prognostic factors for persistent LRS 
complaints after surgery. The percentage of the variance of the model (ideally 100%) was 
only 11%. 
 
Discussion 
 
At 19 months post-surgery 63% of the patient group reported persisting LRS complaints. 
Before surgery 97% of the patients reported severe pain in the leg, which decreased to only 
17% at 19 months post-surgery. Most of the patients were satisfied with their treatment. 
Predictive factors for persisting LRS complaints after surgery were female gender and being 
aged 51-65 years. 
 
Patients operated because of LRS due to a prolapsed disc (at L4-L5 or L5-S1) were 
retrospectively recruited via seven neurosurgeons. Of the 250 patients who were eligible to 
participate in the study, 163 participated. The reasons why the remaining 87 patients 
declined to participate are not known, and it is unknown to what extent this might have 
biased the results of the study. 
The first measurement took place 6 months post-surgery. Because the patients were asked 
to recall their LRS complaints before surgery, we cannot exclude the possibility of some 
recall bias. 
 
In 1989 both Habbema et al.35 and Braakman et al.36 reported on the health status of 
patients undergoing surgery due to LRS in the Netherlands. At 1 year post-surgery 35% of 
the patients (n=361) reported pain in the leg35, whereas in the present study 55% reported 
pain in the leg, 44% sensory deficits, and 30% reported decreased muscle strength in the leg. 
Braakman et al.36 reported that, compared with the physical examinations, patients 
underreported decreased muscle strength in the leg. Comparison of the results of our study 
with those of earlier studies is difficult because of differences in methodology, follow-up 
periods and outcome measures. 
 
The prognostic factors reported in this study should be interpreted with some caution 
because the percentage of variance of the model was only 11%. Many studies28,38,40,41,44 have 
reported gender as a prognostic factor, but other studies25,26,30 did not. Jogging has also been 
mentioned, but mainly as a factor for developing LRS.45 In the present study being aged 51 
to 65 years was found to be a prognostic factor for persisting LRS, whereas in other studies 
age was not a prognostic factor.28,41-43 
 
Conclusion 
 
In the present study over half of the patients reported LRS complaints 19 months after 
surgery, and most were satisfied with their treatment. However, because we were unable to 
establish the effectiveness of surgery in patients with LRS, a randomised controlled trial 
should be performed in a similar group of patients. 
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Abstract 
 
Background Patients with a lumbosacral radicular syndrome are mostly treated 
conservatively first. The effect of the conservative treatments remains controversial. 
Objective To assess the effectiveness of conservative treatments of the lumbosacral radicular 
syndrome (sciatica). 
Search strategy Searched were relevant electronic databases and the reference lists of articles 
up to May 2004. 
Selection criteria Randomised clinical trials of all types of conservative treatments for 
patients with the lumbosacral radicular syndrome selected by two reviewers. 
Data collection and analysis Two reviewers independently assessed the methodological 
quality and the clinical relevance. Because the trials were considered heterogeneous we 
decided not to perform a meta-analysis but to summarise the results using the rating system 
of levels of evidence. 
Results Thirty trials were included that evaluated injections, traction, physical therapy, bed 
rest, manipulation, medication, and acupuncture as a treatment for the lumbosacral 
radicular syndrome. 
Conclusions We do not recommend corticosteroid injections and traction as treatment 
option because several trials indicated no evidence of an effect. Whether clinicians should 
prescribe physical therapy, bed rest, manipulation or medication could not be concluded 
from this review. At present there is no evidence that one type of treatment is clearly 
superior to others, including no treatment, for patients with a lumbosacral radicular 
syndrome. 
 
Introduction 
 
The lumbosacral radicular syndrome (LRS), also called sciatica, is a disorder with radiating 
pain in one or more lumbar or sacral dermatomes, and can be accompanied by phenomena 
associated with nerve root tension or neurological deficits.2,4,5,16 A prolapsed disc mostly 
causes LRS, but other causes include spinal or lateral recess stenosis, tumours or 
radiculitis.1,2 The incidence of LRS in general practice in the Netherlands is estimated 
between 60,000 and 75,000 a year.1 
 
Most patients with LRS are treated conservatively in the first 6 to 12 weeks (acute and 
subacute phase).2 However, the effectiveness of most of the conservative interventions has 
not yet been demonstrated beyond doubt. The review of Vroomen et al.46 about 
conservative treatment of sciatica showed lacking evidence for or against the efficacy of 
traction, exercise therapy or drug therapy for the management of LRS. 
They reported that epidural steroids may be beneficial for subgroups of nerve root 
compression. Vroomen et al. searched literature between 1966 and March 1998. 
Several new RCT’s have been published since, so an updated review on the whole spectrum 
of conservative management in LRS seems indicated. Also, recent developments in the 
methodology of systematic reviews are included in the present review and finally more 
specific physical therapy databases were searched. 
 
The aim of this systematic review was to assess the effectiveness of conservative treatments 
in the lumbosacral radicular syndrome when compared to placebo, inactive or no 
treatment, other forms of conservative care or surgery. 
 
Criteria for considering studies for this review 
 
Types of studies 
Only randomised clinical trials (RCTs) published in English, Dutch, French and German 
were included. Excluded were abstracts of which full reports were not available and 
unpublished studies. 
 
Types of participants 
Included were patients with an acute (less than 6 weeks), subacute (6-12 weeks) or chronic 
(12 weeks or more) lumbosacral radicular syndrome treated in a primary health care or 
occupational setting. Excluded were patients with LRS, which focus on rarely occurring 
causes such as tumours and radiculitis. 
 
Types of interventions 
All types of conservative treatment such as oral medication (e.g. NSAIDs, muscle relaxants), 
injections, physical therapy, spinal manipulation, bed rest, traction and acupuncture were 
included. Comparisons investigated were: (1) conservative treatment versus placebo, 
inactive or no treatment, (2) conservative treatment versus other type(s) of conservative 
treatment, and (3) conservative treatment versus surgery. 
 
Types of outcome measures 
Studies were included that used at least one of the four primary outcome measures that we 
considered to be the most important47, that is an outcome of symptoms (e.g., pain), overall 
improvement (e.g., proportion of patients recovered, subjective improvement of 
symptoms), function (e.g., Roland Disability Questionnaire for sciatica, Oswestery Scale), 
and return to work (e.g., days off work). 
Outcomes of physiological or physical examinations (e.g., range of motion, spinal flexibility, 
degrees of straight leg raising or muscle strength), quality of life (e.g., SF-36, Nottingham 
Health Profile, Sickness Impact Profile) and psycho-social outcomes (anxiety, depression, 
pain behaviour) were considered as secondary outcomes. Other outcomes such as medical 
consumption and side effects were also considered. 
The treatment outcomes were assessed at short-term follow-up (less than 3 months after 
randomisation), at intermediate follow-up (between 3 months and 1 year after 
randomisation) and at long-term follow-up (1 year or more after randomisation). 
 
Search strategy for identification of studies 
We used the search strategy recommended by the Editorial Board of the Cochrane 
Collaboration Back Review Group.47 
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The highly sensitive search strategies for retrieval of studies of controlled trials48 was run in 
conjunction with a specific search for the lumbosacral radicular syndrome and conservative 
treatments. 
All relevant studies meeting our inclusion criteria were identified by: (1) Searches in 
electronic database: PUBMED-MEDLINE (from 1966 to May 2004), EMBASE (from 1980 
to May 2004), Cochrane Central Register of Controlled Trials (CENTRAL, from 1800 to 
2004)49 , Cinahl (from 1982 to May 2004), PsycINFO (psychological interventions from 
1984 to May 2004), and PEDro (Physiotherapy Evidence Database to May 2004 ), and (2) 
Screening the references of all studies selected from the electronic databases searches and 
relevant reviews. 
 
Methods 
 
Study selection 
One reviewer (PL) performed the search strategy. Two reviewers (PL and TvO) 
independently selected the studies to be included in the systematic review. First, they 
screened the title, keywords and abstract for eligibility. Secondly, they assessed the full text 
papers whether the study met the inclusion criteria regarding design, subjects, and 
intervention. Disagreements on inclusion are resolved by discussion, or through arbitration 
by a third reviewer (AV).  
 
Methodological quality assessment 
Two reviewers (PL and RO) independently assessed the methodological quality (MQ), 
using the Delphi list.50 The Delphi list contains 9 items relevant for the internal validity of 
each of the assessed articles. Each item was rated as ‘yes’, ‘no’, or ‘don’t know’ (insufficient 
or no information presented). Equal weights were applied that resulted in a total score of 
each RCT, by adding the ‘yes’ scores (range 0-9). Disagreements were solved in a consensus 
meeting. When disagreements persisted a third reviewer (AV) was consulted. 
 
Clinical relevance 
Two reviewers (WP and BK) independently assessed the clinical relevance (CR). The 
Cochrane Collaboration Back Review Group recommends the 5 questions used to judge 
clinical relevance.47 Disagreements were solved in a consensus meeting. When 
disagreements persist a third reviewer (AV) was consulted. A study was considered clinical 
relevant if the questions 1, 2 and 3 scored ‘Yes’. 
 
Data extraction 
One reviewer (PL) extracted the data of the included RCTs. In cases of uncertainly about 
the data extracted from the individual trials a second reviewer (AV) was consulted. 
 
Data analysis 
The inter-observer reliability of the quality assessments was calculated using Kappa (< 0.5 
means a poor level of agreement between assessors; between 0.5 and 0.7 a moderate level of 
agreement, and > 0.7 a high level of agreement).51 A high quality (HQ) RCT was defined as 
a study that had a positive score (yes) on five or more Delphi criteria (score ranging from 0 
to 9). 
The data of the effect measurements reported in each study are presented as relative risks 
(RR) with corresponding 95% confidence intervals for dichotomous data and effect sizes 
(ES) and 95% confidence intervals for continuous data. 
Quantitative analysis 
Statistical pooling (meta-analysis) of the study outcomes (using a random effect model) will 
be performed if the studies are considered clinically homogeneous. 
 
Qualitative analysis 
If the studies are considered to be heterogeneous, the factors possibly underlying this 
phenomenon are considered. The results are summarized using a rating system that 
consists of five levels of scientific evidence which have been used in previous systematic 
reviews in the field of back pain, based on the overall quality and the outcome of the 
studies47: 1) strong evidence - consistent findings in multiple high quality RCTs, 2) 
moderate evidence - consistent findings among multiple low quality RCTs and/or one high 
quality RCT, 3) limited evidence - one low quality RCT, 4) conflicting evidence - 
inconsistent findings among multiple RCTs and 5) no evidence - no RCTs. 
 
Results 
 
Description of studies 
The search strategy in the electronic databases selected 794 titles to be screened by two 
reviewers (PL and TvO). Disagreements were discussed and solved; 30 RCTs were included 
which were published in English and in French. Figure 1 shows the flow chart of the 
selection process. 
 
Figure 1: Flow chart of the selection process 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
RCTs identified in databases and screened by two reviewers (n=794)
RCTs retrieved for full text examination (n=67)
Excluded RCTs based on title and abstract because no 
randomised clinical trial or participants had no sciatica or no 
group of participants was treated conservative (n=727) 
Excluded RCTs because no randomised clinical trial or 
participants had no sciatica or no commen cause of sciatica or 
no group of participants was treated conservative (n=33) 
Potentially appropriate RCTs to be included (n=34)
Excluded RCTs because double publication or no between-
group comparison (n=4) 
RCTs included in this review (n=30)
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The 30 publications included in total 2780 patients with LRS and evaluated injections 
(n=14), traction (n=9), physical therapy (n=4), bed rest (n=2), manipulation (n=2), 
medication (n=2) and acupuncture (n=1). In 18 RCTs the sample size was small, meaning 
less than 30 patients in one study arm. 
 
Methodological quality of the included studies 
The two reviewers (PL and RO) agreed on 230 of the 270 item scores (85.2%). The inter-
observer reliability of the MQ assessment (kappa=0.70) was moderate. Disagreements were 
solved in consensus for most cases, the third reviewer (AV) had to decide 5 times (1.8%). 
Detailed results of the MQ assessment are presented in tables 1 to 7. Twelve studies (40.0%) 
of the 30 included RCTs were considered to be of high quality. The overall MQ score 
ranged from 2 to 9 out of maximal 9 points. The most prevalent shortcomings of the studies 
concerned: no adequate description of treatment allocation concealment (n=27), no 
attempt to blind the care provider (n=26) or the analysis did not include an intention-to-
treat analysis (n=23). 
 
Clinical relevance 
The two reviewers (WP and BK) agreed on 125 of the 150 item scores (83.3%). The inter-
observer reliability of the clinical relevance assessment (kappa=0.67) was moderate. 
Disagreements were solved in consensus for all cases. Detailed results of the clinical 
relevance assessment are presented in tables 1 to 7. The overall clinical relevance score 
ranged from 0 to 5 out of maximal 5 points. Ten studies (33.3%) were considered clinical 
relevant because a ‘Yes’ was scored on the first 3 questions.  
Finally, 6 RCTs4,52-56 were considered to be of high quality and clinical relevant. Five RCTs52-
56 evaluated injections and 1 RCT4 medication. 
 
Evidence of effectiveness 
Even in subgroups according to the intervention the included RCTs were not considered 
clinically comparable concerning study population (duration of the LRS), control 
treatment, duration of follow-up, and outcome measures. Because of this heterogeneity we 
refrained from statistical pooling and performed a qualitative analysis. 
 
Injections 
Table 1 shows the characteristics of fourteen studies that compared injection to placebo (9 
RCTs), to no treatment (2 RCTs) and to other injections (4 RCTs). 
 
Versus placebo 
Nine studies52-55,57-61 compared epidural or extradural corticosteroid injection to placebo 
injection. Six studies were considered high quality52-55,58,60 of which one study60 did not 
provide any data. 
In three high quality studies52,53,55 and one low quality study59, we found no difference in 
pain between injection and placebo at short-term. However, in another one high quality54 
and one low quality study61 we found an effect in pain at short-term, in favor of injection. 
In three high quality studies52,55,58 and one low quality study57, we found no difference in 
overall improvement between injection and placebo at short-term. However, in another low 
quality study59 we found an effect in improvement, in favor of injection. 
Long-term effects for pain and overall improvement were not found in two high quality 
studies54 and one low quality study.61 Also, no short or long-term effects were found for 
disability and return to work in three high quality studies.52-54 
In conclusion, when comparing corticosteroid injections to placebo for patients with LRS 
we found conflicting evidence regarding pain and overall improvement at short-term 
follow-up and no difference (2 HQ, 1 LQ trials: strong evidence) at long-term follow-up. 
For disability and return to work we found no difference (3 HQ trials: strong evidence) at 
short and long-term follow-up. 
 
Versus no treatment 
Two studies57,62 compared epidural corticosteroid injection to no injection. In both studies, 
one of high quality62 and one of low quality57, we found no difference in overall 
improvement and return to work between groups. Therefore, when comparing 
corticosteroid injections to no treatment for patients with LRS we found no difference (1 
LQ trial: limited evidence) regarding overall improvement at short-term follow-up and no 
difference (1 HQ trial: moderate evidence) regarding return to work at intermediate follow-
up. 
 
Versus other injections 
Four studies56,63-65 compared epidural or intramuscular corticosteroid injection to an 
injection of a NSAID or an anaesthetic. In one high quality56 and two low quality studies63,65 
we found no difference in pain and return to work at short-term. However, in another low 
quality study64 we found a difference in pain at short-term, in favor of corticosteroid 
injection. In one high quality study56 we found a difference in pain at intermediate follow-
up, in favor of injection with radioscopic control. In one low quality study63 we found no 
difference in pain at long-term. 
In one high quality study56 we found a difference in disability at short-term and 
intermediate follow-up, in favor of injection with radioscopic control.  
Therefore, we conclude there is conflicting evidence for the benefit of corticosteroid 
injection above an injection with a NSAID or anaesthetic regarding pain at short-term 
follow-up. There is moderate evidence that an injection with radioscopic control is more 
effective than injection without radioscopic control regarding pain at intermediate follow-
up and regarding disability at short-term and intermediate follow-up for patients with LRS. 
No difference (2 LQ trials: moderate evidence) between injections was found regarding 
return to work at short-term follow-up and regarding pain at long-term follow-up. 
 
Traction 
Table 2 shows the characteristics of nine studies that compared traction to inactive/sham 
traction (4 RCTs) and to another conservative treatment (5 RCTs). 
 
Versus inactive/sham traction 
Four studies66-69 compared traction to inactive/sham traction. One low quality study67 did 
not report any data. 
In one high quality69 and one low quality study66 we found no difference in pain between 
traction and inactive/sham traction at short-term. Also, in one low quality study68 we found 
no difference in improvement between groups at short-term. 
Therefore, when comparing traction and inactive/sham traction for patients with LRS we 
found no difference (1 HQ, 2 LQ trials: moderate evidence) regarding pain and disability at 
short-term follow-up. 
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Versus other conservative care 
Five studies70-74 compared traction to an other conservative treatment. All five studies were 
considered of low quality. In one study70 we found a difference between traction and other 
conservative care in overall improvement, in favor of traction. However, in three studies72-74 
we found no difference in overall improvement between groups. In one study72 we found no 
difference in pain between traction and other treatments, but in another study71 we found a 
difference in pain, in favor of traction. In one study72 we found no difference in return to 
work between groups. 
Therefore, when comparing traction to other conservative treatments for patients with LRS 
we found conflicting evidence regarding improvement and pain at short-term follow-up. 
We found no difference (1 LQ trial: limited evidence) regarding return to work at short-
term follow-up. 
 
Physical therapy 
Table 3 shows the characteristics of four studies that compared physical therapy to inactive 
treatment (1 RCT), to other conservative care (2 RCTs) and to surgery (1 RCT). 
 
Versus inactive treatment 
In one high quality study75 we found no difference in pain and disability at short and 
intermediate follow-up between the groups. 
Therefore, when comparing physical therapy to inactive treatment for patients with acute 
LRS we found no difference (1 HQ trial: moderate evidence) regarding pain and disability at 
short and intermediate follow-up. 
 
Versus other conservative care 
Two low quality studies70,72 compared physical therapy to other conservative treatments. In 
these studies we found no difference in overall improvement, pain and return to work 
between groups.  
Therefore, when comparing physical therapy to other conservative care for patients with 
LRS we found no difference (2 LQ trials: moderate evidence) regarding overall 
improvement, pain and return to work at short-term. 
 
Versus surgery 
In one low quality study25 we found a difference in improvement at 1 year follow-up, in 
favor of surgery. In the same study we found no difference in improvement at 4 and 10 
years follow-up between the two groups. 
Therefore, we conclude there is limited evidence that surgery is more effective for patients 
with LRS regarding overall improvement than physical therapy at 1-year follow-up. At 4 
and 10-year follow-up we found no difference (1 LQ trial: limited evidence) regarding 
overall improvement between surgery and physical therapy. 
 
Bed rest 
Table 4 shows the characteristics of two studies that compared bed rest to no treatment. In 
one low quality study17 we found no differences in overall improvement, pain, and disability 
at short-term follow-up between the groups. In one high quality study75 we found no 
differences in pain, disability, at short and intermediate follow-up between the groups. 
 
 
Therefore, when comparing bed rest to no treatment for patients with acute LRS we found 
no difference (1 HQ, 1 LQ trial: moderate evidence) regarding overall improvement at 
short-term follow-up and no difference (1 HQ trial: moderate evidence) regarding pain and 
disability at short and intermediate follow-up. 
 
Manipulation 
Table 5 shows the characteristics of two studies that compared manipulation to other 
conservative care (1 RCT) and to surgery (1 RCT). 
 
Versus other conservative care 
In one low quality study72 we found no difference in overall improvement, pain and return 
to work between the groups. Therefore, when comparing manipulation to other 
conservative care for patients with LRS we found no difference (1 LQ trial: limited 
evidence) regarding overall improvement, pain and return to work at short-term follow-up. 
 
Versus chemonucleolysis 
In one low quality study76 we found no differences in pain and disability between the 
groups. Therefore, when comparing manipulation to chemonucleolysis for patients with 
LRS we found no difference (1 LQ trial: limited evidence) regarding pain and disability at 
short and long-term follow-up. 
 
Medication 
Table 6 shows the characteristics of two studies that compared medication to placebo. In 
one high quality study4 we found no difference in sick leave between the groups. In one low 
quality study77 we found no difference in overall improvement between the groups. 
Therefore, when comparing piroxicam or tizanidine to placebo for patients with acute LRS 
we found no difference (1 HQ, 1 LQ trial: moderate evidence) regarding overall 
improvement and sick leave at short-term follow-up. 
 
Acupuncture 
Table 7 shows the characteristics of a high quality study78 that compared acupuncture to 
placebo. No data were presented in this article. Therefore, we conclude there is no evidence 
of the effectiveness of acupuncture for patients with LRS. 
 
Discussion 
 
This systematic review included 30 RCTs with a total of 2780 patients with LRS that 
evaluated various conservative treatments. Twelve of the 30 included studies were of high 
methodological quality and 10 studies were considered clinical relevant. Based on the 
results of this systematic review regarding the conservative treatment of patients with LRS 
we conclude that: 
1) At long-term there is no evidence in favor of corticosteroid injections when compared 
to placebo, no treatment or NSAID or anaesthetic injection, apart from conflicting 
evidence for short-term pain relief. 
2) At short-term there is no evidence in favor of traction when compared to sham traction 
or other conservative treatments. 
3) At short-term there is no evidence in favor of physical therapy compared to inactive 
treatment, other conservative treatments or surgery. 
4) At short-term there is no evidence in favor of bed rest compared to no treatment. 
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5) At short-term there is no evidence in favor of manipulation compared to other 
conservative treatments or chemonucleolysis. 
6) At short-term there is no evidence in favor of medication compared to placebo. 
7) No evidence was found regarding acupuncture. 
 
In this review, like every review, there are risks of publication and language bias. There are 
indications that studies with negative results are not easily published as positive studies.79,80 
Furthermore, relevant studies, which are registered in unknown databases may not be 
included. Because of our extensive search strategy this risk was considered small. 
Although efforts were made to find all published RCTs in restricted languages (i.e. English, 
Dutch, French and German), some relevant studies published in other languages might 
have been missed. Also, the number of non-English journals indexed in searched electronic 
databases is limited. 
 
There was an overall clinical heterogeneity of the included studies. There appeared tot be 
many differences in study populations i.e. the duration of LRS, interventions, duration of 
follow-up and outcome measures. 
It was considered clinically inappropriate to pool the results of the RCTs in the different 
types of conservative treatments. Therefore a qualitative analysis was performed, using the 5 
levels of evidence.47 Although the levels of evidence used may be considered arbitrary, it 
seems unlikely that a different rating system would have resulted in different conclusions. 
But, in this review we included studies that almost all reported no differences in outcomes 
between intervention and control group. When finding no differences between groups we 
cannot conclude ‘there is evidence that the intervention is not effective or not different 
from the control treatment’.81 Recommended by the Cochrane Collaboration than is to 
conclude that there is ‘no evidence for an effect’. The analyses according the 5 levels of 
evidence are useful when significant differences are reported between treatment groups. 
But, when no differences between groups are reported in the majority of the included 
studies we found it problematic to use the levels, because we cannot conclude for example: 
‘there is strong evidence for no evidence of an effect’. Therefore, we have chosen to 
conclude with statements such as: ‘we found no differences between groups’. The question 
remains how many trials are needed or how strong must the evidence be, to conclude that a 
treatment is not effective. 
 
The methodological quality of the majority of the included studies, although improving 
over the past several years, was not high. Only 12 of the 30 included studies were regarded 
of high methodological quality. There is, however, a difficulty in blinding the patients and 
care provider during most conservative treatments that cannot be compared with placebo 
(i.e. bed rest, physical therapy, manipulation and traction).  
There were studies with small sample sizes available for inclusion in this review. The 
number of patients in the groups was often too small to reach an adequate statistical power; 
only 12 studies had groups, that each consisted of over 30 patients, included. 
The methodological quality might have been misclassified. Relying on the information in 
reported RCTs may create bias due to underreporting. But the risk of misclassification is 
considered small because a valid and reliable criteria list was used.82 
 
The conclusions of this review that included 30 trials are not all in accordance with the 
conclusions of the review of Vroomen et al.46 that included 19 trials. 
We included more trials that evaluated corticosteroid injections and found no evidence of 
effect at short or at long-term follow-up. Also regarding traction we found more trials with 
no evidence of effect at short-term follow-up. Therefore, we do not recommend these two 
treatment options for patients with LRS. For the other conservative treatment options 
(physical therapy, bed rest, manipulation and medication) no evidence of effect was found 
at short-term follow-up, and long-term effects are unknown. At present there is no evidence 
that one type of treatment is clearly superior for patients with a lumbosacral radicular 
syndrome. 
 
Conclusions 
 
Implications for practice 
In the conservative treatment of patients with LRS we do not recommend clinicians to use 
corticosteroid injections and traction because several trials indicated no evidence of an 
effect. Whether clinicians should prescribe physical therapy, bed rest, manipulation or 
medication could not be concluded from this review. For acupuncture no evidence was 
found. 
 
Implications for research. 
There is no knowledge whether corticosteroid injection could play a role in short-term pain 
relief. Also unknown are the long-term effects of traction, physical therapy, bed rest, 
manipulation or medication. We recommend high quality RCTs of sufficient sample size 
with long-term follow-up concerning physical therapy, manipulation or medication for 
patients with LRS. The outcome measures should include overall improvement, patients’ 
satisfaction, severity of pain in the leg, functional health status, quality of health status, 
return to work and side effects. 
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Chapter 6 
 
Conservative treatment in patients with an acute lumbosacral radicular syndrome: 
design of a randomised clinical trial [ISRCTN68857256] 
 
Pim A.J. Luijsterburg, Arianne P. Verhagen, Raymond W.J.G. Ostelo, Hans J.M.M. van den 
Hoogen, Wilco C. Peul, Cees J.J. Avezaat, Bart W. Koes. 
BMC Musculoskelet Disord 2004;5:39. 
 
 
Abstract 
 
Background The objective is to present the design of randomised clinical trial (RCT) on the 
effectiveness of physical therapy added to general practitioners’ management compared to 
general practitioners’ management only in patients with an acute lumbosacral radicular 
syndrome (also called sciatica). 
Methods/Design Patients in general practice diagnosed with an acute (less than 6 weeks) 
lumbosacral radicular syndrome and an age above 18 years are eligible for participation. 
The general practitioners’ treatment follows their clinical guideline. The physical therapy 
treatment will consist of patient education and exercise therapy. The primary outcome 
measure is patients reported global perceived effect. Secondary outcome measures are 
severity of complaints, functional status, health status, fear of movement, medical 
consumption, sickness absence, costs and treatment preference. The follow-up is 52 weeks. 
Discussion Treatment by general practitioners and physical therapists in this study will be 
transparent and not a complete “black box”. The results of this trial will contribute to the 
decision of the general practitioner regarding referral to physical therapy in patients with an 
acute lumbosacral radicular syndrome. 
 
Background 
 
Why a design article? 
Publishing the design of the trial has several advantages. It may prevent publication bias.83 
A study producing positive results seems more likely to be published than a study that 
reports no or negative results.79,80 Also, the study can be included in systematic reviews 
because data can be retrieved from the researcher.79 Publishing the design of a study before 
the results are available provides an opportunity to reflect critically on the design of the 
study, irrespective of the results. Also, a design article provides detailed information about 
the intervention within the trial to care givers. 
 
The lumbosacral radicular syndrome (LRS) is a complex of symptoms related to the 
lumbosacral nerve roots. The LRS is a disorder with radiating pain in the leg below the knee 
in one or more lumbar or sacral dermatomes, and can be accompanied by phenomena 
associated with nerve root tension or neurological deficits (i.e. sensory deficits in the leg, 
decreased muscle strength in the leg, decreased reflexes, urinary problems).2,4,11,16 A 
prolapsed disc is a frequent cause of LRS, but other causes include spinal or lateral recess 
stenosis, tumours and radiculitis.1,2,4,11 The incidence of LRS in the Netherlands is estimated 
at 5 per 1000 persons a year.1 
 
 Most patients seeking medical care in the Netherlands will first visit a general practitioner 
(GP), who is regarded as the ‘gatekeeper’ of the health care system. The majority of health 
problems presented to GPs are treated by the GPs themselves and they are responsible for 
most referrals to (para) medical specialists. In 1996 the Dutch College of General 
Practitioners published their clinical guideline for LRS.11 There is consensus that treatment 
of LRS in the first six to eight weeks should be conservative. The exact content of the 
conservative treatment is yet not clear.46 Since the study of Vroomen et al.17 bed rest is not 
regarded a treatment option for LRS anymore. 
 
Primarily, treatment consists of adequate pain medication, giving information about the 
natural course of LRS, which in general is favourable, and stimulating to continue the 
normal daily activities of the patient. GPs in the Netherlands largely comply with the 
recommendations stated in the clinical guideline regarding management in patients with 
LRS.84 However, they deviated regarding the referral to physical therapy (PT), almost half of 
patients with LRS were referred, whereas this was not recommended in the guideline. No 
specific patients characteristics could be found for the prescription of physical therapy. So, 
in general practice referral to PT in patients with LRS is common. However, there is a lack 
of knowledge of the effectiveness of PT in LRS. Therefore, the aim of this article is to 
present the design of a randomised clinical trial of conservative treatment (general 
practitioners and physical therapy) in patients with acute LRS. 
 
Methods/Design 
 
Aim 
The LRS trial aims to assess the effectiveness of PTs’ management added to GPs’ 
management compared to GPs’ management only in patients with acute LRS. We will use a 
multicentre, randomised clinical trial as study design. Figure 1 shows the flow chart of the 
proposed design of the LRS trial. The procedures and design of this study are approved by 
the Erasmus Medical Center Ethics Committee. 
 
Study population 
Participating GPs in and around Rotterdam, the Netherlands, will invite patients with 
suspected acute LRS to participate in the trial. GPs will invite patients from May 2003 till 
November 2004 if they have radiating (pain) complaints in the leg below the knee; duration 
of the (pain)complaints is less than 6 weeks, the age is above 18 years and they present one 
of the following symptoms: more pain on coughing, sneezing or straining, decreased muscle 
strength in the leg, sensory deficits in the leg, decreased reflex activity in the leg or a positive 
straight leg raising test. Patients will receive a letter of information about the LRS trial from 
their GP. Patients’ name and telephone number will be faxed to the research institute. 
Subsequently, a researcher (PL) will screen eligible patients by telephone and make an 
appointment to check inclusion and exclusion criteria, to complete the informed consent 
procedure and to perform the baseline measurement. 
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Figure 1: Flow chart of the LRS trial 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2 shows the criteria that must be fulfilled to participate in the LRS trial. A research 
assistant will check these criteria during patients first visit. The informed consent procedure 
is completed when patients meet the criteria, are willing to participate and give their written 
consent. Hereafter, the baseline measurement will take place. 
 
Figure 2: Selection criteria for trial eligibility 
 
Inclusion: 
Radiating (pain) complaints in the leg below the knee 
Severity of complaints scored above 3 on a 10 point VAS (0= no complaints; 10= maximum complaints) 
Duration of the (pain) complaints less than 6 weeks 
Age above 18 years 
Able to speak and read Dutch 
Presents of one of the following symptoms: 
More pain on coughing, sneezing or straining 
Decreased muscle strength in the leg 
Sensory deficits in the leg 
Decreased reflex activity in the leg 
Positive straight leg raising test 
 
Exclusion: 
Radiating (pain) complaints in the preceding 6 months 
Back surgery in the past 3 years 
Treated with epidural injections 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Patients with LRS referred by GPs
Screening for eligible patients by telephone
Check inclusion criteria 
Informed consent 
Baseline measurement 
Randomisation 
Follow-up measurements: 3, 6, 12, 52 weeks 
after randomisation 
GP and PT care GP care
 Exclusion: 
Pregnancy 
Co-morbidity that primary determines overall well being 
Direct indication for surgery (unbearable pain, fast progression of paresis or cauda equina syndrome 
Expected loss to follow-up (i.e. moving towards other part of the country, long lasting foreign holiday) 
 
Randomisation 
Randomisation will take place after baseline measurement by the research assistant. We use 
a concealed randomisation procedure using a computer generated randomisation list 
developed by an independent person. Patients’ specific and unique trial number will be 
typed in a special developed database (i.e. not editable for research assistant and a second 
randomisation action using the same trial number is not possible) and the random 
allocation will appear on screen. In order to prevent unequal treatment group sizes, block 
randomisation will be used with blocks of 10 patients.85 This means that after every 10th 
patient the number of patients allocated to both treatment groups is equal. Towards every 
randomised patient will be explained that the management of their complaint by his or her 
GP will be continued. Patients who are allocated to physical therapy will be shown a list of 
participating physical therapists of which he or she can make a choice. The research 
assistant makes the first appointment with the physical therapist most easily accessible by 
the patient. 
 
Blinding 
For obvious reasons GPs and PTs are not blinded for treatment allocation. But they are not 
involved with treatment effect measurements. The patients cannot be blinded because of 
the ethical reasons as stated by the Medical Ethical Committee. The researcher is involved 
in the statistical analysis, but the analysis and interpretation of the findings will be audited 
and verified by an independent and not involved statistician. In this trial the primary 
outcome measurement and most of the secondary outcome measurements will be scored by 
the patients. Studies from Ostelo et al86 and Scholten-Peeters et al87 mentioned that in this 
type of study patients are blinded to a certain extent because they are unaware of the exact 
content of both treatments or may be called naive to the content of the treatment not 
received. Other more or less similar designed trials from Vroomen et al17 and Hofstee et al75 
reported that it is not possible to blind participating patients for allocated treatment. 
Therefore, we think it is important to know any treatment preference of the patients at 
baseline. Supplementary analysis may show to what extent this effects the scores on 
outcome measurements of the patients. 
 
GP intervention 
All patients will be treated by the GP according to their clinical guideline (see Figure 3). GPs 
will give information and advice about LRS. If necessary they prescribe adequate pain 
medication. We asked the GPs not to refer patients to paramedical specialists (i.e. manual 
therapist, physical therapist, exercise therapist, etc.). Referral to PT is based on 
randomisation and performed by the research assistant. 
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Figure 3: Summary of the clinical guideline ‘Lumbosacral radicular syndrome’ of the Dutch College of General 
Practitioners (1996) 
 
Definition: The lumbosacral radicular syndrome: radiating pain and/or neurological deficits in one or more lumbar 
or sacral dermatomes, often associated with back pain; mostly caused by irritation and compression (traction) of 
the nerve root. 
History taking: Ask about: 1) localisation, radiation, intensity and duration of the pain, 2) influence of rest, 
movement and posture, 3) development of the complaints, 4) interference with daily activities caused by leg pain, 
5) decreased muscle strength and sensory deficits, 6) influence of coughing, sneezing or straining, 7) previous 
history of back complaints, and 8) urinary problems and saddle anaesthesia. 
Physical examination: 1) physical inspection (spine and pelvis), 2) active examination (ante-, retro-, lateroflexion), 
and 3) Lasègue sign and test of Bragard. If there is a positive Lasègue sign, decreased muscle strength or sensory 
deficits perform: 4) ankle tendon reflex and knee tendon reflex, 5) sensory examination of the lateral and medial 
side of the foot, 6) muscular strength of the big toe, walking on heels and toes, and 7) crossed test of Lasègue. 
Additional examinations: X-rays should only be ordered in case of suspicion on malignancy or a fracture due to 
osteoporosis. 
Evaluation: The lumbosacral radicular syndrome should be diagnosed if there are radiating complaints in the leg 
below the knee, plus one of the following findings: 1) a positive Lasègue sign (or Bragard), or 2) neurological 
deficits reducible to a single nerve root. 
Information and advice: Explain to the patient that radiating complaints are caused by a prolapsed disc that gives 
pressure on a nerve in the back. There is a favourable course in 80% of the patients with conservative care. Back 
pain may persist after the leg pain has gone. 
Mild complaints: Advice the patient to perform the usual daily activities but to avoid painful movements. 
Gradually increase the activities. 
Severe complaints: Strict bed rest (washing and toilet visits on bed) for two weeks. When the complaints decrease 
after a few days or two weeks, less strict bed rest (walking, washing and toilet visits allowed). Gradually increase the 
activities to normal level in six weeks and to patients’ level in six to twelve weeks. 
Follow-up: Check the patient with bed rest after two to four days. Evaluate the effect of treatment by checking 
Lasègue sign and the severity of the complaints. Check patients with severe complaints daily and subsequently at 
least once a week. Accompany the patient till full resumption of daily activities. 
Drug treatment: If desired: paracetamol (4-6 dd, 500mg), ibuprofen (3-4 dd, 400 mg), diclofenac (3-4 dd, 25-50 
mg), or naproxen (2-3 dd, 250 mg). 
Referral: Refer in an instant: 1) cauda equina syndrome, or 2) progressive paresis within a few days in spite of 
conservative care. Refer for diagnostics and judgement for indication for surgery: 1) Severe radicular pain in spite 
of bed rest and adequate medication, 2) Severe paresis or progressive paresis in spite of adequate care (walking on 
heels and toes is impossible), 3) doubtful diagnosis, or 4) mild complaints with no improvement after six to eight 
weeks. 
 
PT intervention 
PT treatment will imply information and advice about LRS and exercise therapy. Passive 
modalities such as massage, manipulation techniques or applying applications (e.g. ultra 
sound or current waves) are not allowed in the PT treatment. This PT treatment protocol 
was accomplished in a consensus meeting with participating PTs. The PT will report what 
kind of information/ advice and what type of exercise the patient receives in each session. 
Both GP and PT intervention will be restricted to a maximum of 9 treatments/ 
consultations in the first 6 weeks after randomisation. 
 
 
 
 Theoretical background 
In the Netherlands, PTs are mainly taught the biomechanic model.86 This model focuses on 
somatic issues; it assumes a causal relation between tissue damage and pain. PT could be of 
additional value in the management of patients with LRS because PTs are ‘the experts’ in 
treating musculoskeletal disorders with exercises and advice/ information. The pain 
reported by a patient is used as guidance to determine the intensity of the exercises and the 
advice about resuming normal daily activities and work. This study assumes that focussing 
on (pain) complaints with exercises and advice is the optimal PT treatment in the acute 
phase (0 to 6 weeks) of LRS. It is possible that patients may suffer from a fear of movement 
because of pain.88 Good advice/ information will reassure these patients and exercises will 
show them that movement is possible. So, the secondary treatment goal of the PT is to 
decrease the possibly present fear of movement in these patients. 
 
Sample size 
This trial attempts to enrol 182 patients with LRS, 91 patients in both treatment groups. 
This sample size is regarded sufficient to detect a difference of 20% (with a α of 0.05 and a 
power of 80%) in the primary outcome (GPE) between the two treatment groups. A 
difference of 20% is considered to be clinically relevant.89 
 
Measurements 
Figure 4 shows the outcome measures and the points of time they are collected. At baseline 
we will collect patients characteristics such as gender, date of birth, height and body weight. 
In standardised history taking there will be established whether patients are familiar with 
LRS in the past, report more pain in the leg on coughing/ sneezing or straining, on sitting, 
standing, walking and lying down, and if patients report a decreased muscle strength and 
sensory deficits in the leg. The physical examination consists of the straight leg raising test, 
the crossed straight leg raising test, test of Bragard, finger-floor distance, standing on toes 
and heels, knee tendon reflex, ankle tendon reflex, strength of m. extensor hallicus longus, 
sensory tests (touch, sharp and blunt) in the dermatomes L5/ S1 in the feet. 
 
Figure 4: Data collection and outcome measures 
 
 Baseline 3 weeks 6 weeks 12 weeks 52 weeks 
Inclusion/ exclusion X     
Patient characteristics X     
History taking X  X X  
Physical examination X  X X  
Global perceived effect (7-points scale) X X X X X 
Severity of complaints (VAS) X X X X X 
Functional status (RDQ) X  X X X 
Health status (SF-36/ EQ-5D) X  X X X 
Fear of movement (TSK) X    X 
Medical consumption X X X X X 
Sickness absence X X X X X 
Costs X X X X X 
Treatment preference X X X X X 
VAS=visual analogue scale; RDQ=Roland Morris disability questionnaire for sciatica; SF-36=Short form 36 
questionnaire; EQ-5D=Euroqol, TSK=Tampa scale for kinesiophobia. 
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Primary outcome measure 
The primary outcome measure is the Global Perceived Effect (GPE), measured on a 7 
points scale ranging from 1=completely recovered to 7=vastly worsened. It is regarded a 
clinical relevant outcome measure and is regarded valid and responsive to measure the 
patients’ perceived benefit.90-92 
 
Secondary outcome measures 
Pain severity of the leg and the back will be scored on a 11 points Visual Analogue Scale 
(VAS) ranging from 0=no pain to 10=unbearable pain. Reliability, validity and 
responsiveness of the VAS have been shown.93-95 
The functional status will be measured with the Roland Morris Disability Questionnaire 
(RDQ) for sciatica.96 The scoring of the RDQ is achieved by counting the number of 
positive responses: a patient individual score can vary from 0 (no disability) to 24 (severe 
disability). The RDQ has proved to be a valid instrument and appears to be responsive for 
clinical relevant changes.92,97-100 
Health status will be measured by the 36-item short form (SF-36)101  and the Euroqol (EQ-
5D) instrument.102,103 Validity and responsiveness on both SF-36104-106 and EQ-5D107-109 
proved to be sufficient. 
Fear of movement will be measured by the Tampa scale for kinesiophobia (TSK).110,111 The 
TSK consists of 17 items; each rated on a 4-point likert scale. The TSK has been shown to be 
a valid and responsive instrument.112,113 
Costs will be calculated and include LRS related sickness absence from work, medical 
consumption (i.e. medication use, additional therapies, visits to health care providers), out-
of-pocket expenses and paid help. Patients’ treatment preference will be evaluated at 
baseline and at 4 follow-up measurements. 
 
Statistical analysis 
Baseline comparability will be investigated by descriptive statistics to examine whether 
randomisation was successful. If necessary, adjustments for baseline variables will be 
performed in the analysis. Group differences and 95% confidence intervals will be 
calculated for all outcome measures. The statistical analysis will be performed according tot 
the intention-to-treat principle, analysing the patients in the treatment group to which they 
were randomly allocated. Between group differences will be calculated using the Student t-
test for continuous variables or Chi-Square for dichotomous variables. In addition a per-
protocol analysis will be performed, analysing only those patients with no serious protocol 
deviations. Comparing the results of the intention-to-treat and the per-protocol analysis 
will indicate if and to what extent protocol deviations might have biased the results. 
Multivariate regression analysis will be conducted to examine the influence of baseline 
variables on outcome. 
 
Discussion 
 
This article introduces a design of a RCT to evaluate the additional effectiveness of PTs’ 
management added to GPs’ management in patients with LRS. The study is designed in a 
way that GP and PT treatment is transparent (according a guideline and a consensus 
meeting) and not a complete “black box”. The results of this trial will contribute to the 
decision of the GP regarding referral of patients with LRS to PT. The inclusion of patients 
will run until the end of the year 2004. The follow-up measurements will be completed in 
the end of the year 2005. 
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Effectiveness of physical therapy plus general practitioners’ care versus general 
practitioners’ care alone for sciatica. A randomised clinical trial with 1-year follow-up. 
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Abstract 
 
Objective To assess the effectiveness of physical therapy additional to general practitioners’ 
care compared to general practitioners’ care alone, in patients with acute sciatica. 
Design, setting and patients A randomised clinical trial in primary care with a 12-months 
follow-up period. 135 patients with acute sciatica (recruited from May 2003 to November 
2004) were randomised in two groups: 1) the intervention group received physical therapy 
added to the general practitioners’ care, and 2) the control group with general practitioners’ 
care only. 
Intervention Physical therapy consisting of active exercises added to general practitioners’ 
care. 
Main outcome measures The primary outcome was patients’ global perceived effect. 
Secondary outcomes were severity of leg and back pain, severity of disability, general health 
and absence from work. The outcomes were measured at 3, 6, 12 and 52 weeks after 
randomisation. 
Results At 3 months follow-up, 70% of the intervention group and 62% of the control group 
reported improvement (RR 1.1; 95% CI 0.9; 1.5). At 12 months follow-up, 79% of the 
intervention group and 56% of the control group reported improvement (RR 1.4; 95% CI 
1.1; 1.8). No significant differences in secondary outcomes were found at short-term or 
long-term follow-up. 
Conclusions At 12 months follow-up, evidence was found that physical therapy added to 
general practitioners’ care is more effective in the treatment of patients with acute sciatica 
than general practitioners’ care alone. There are indications that physical therapy is 
especially effective in patients reporting severe disability at presentation. 
Trial registration An International Standard Randomised Controlled Trial Number was 
assigned to this trial (ISRCTN68857256) at www.controlled-trials.com. 
 
Introduction 
 
The lumbosacral radicular syndrome (LRS), also called sciatica, is a disorder with radiating 
pain in the leg below the knee in one or more lumbar or sacral dermatomes, and can be 
accompanied by phenomena associated with nerve root tension or neurological deficits.2-4,11 
A prolapsed disc is a frequent cause of LRS, but other causes include spinal or lateral recess 
stenosis, tumours and radiculitis.1,2,4,11 The incidence of LRS in the Netherlands is estimated 
at 5 per 1000 persons a year.1 Most patients seeking medical care in the Netherlands will 
first visit a general practitioner (GP). 
In 1996 the Dutch College of General Practitioners published their clinical guideline for 
LRS11 and updated it in 2005.5 There is consensus that treatment of LRS in the first 6 to 8 
weeks should be conservative. 
 The exact content of the conservative treatment is, however not yet clear.46 After the study 
of Vroomen et al.17 bed rest is no longer regarded as a treatment option for LRS.5 
 
GPs in the Netherlands largely comply with the recommendations stated in the clinical 
guideline regarding the management of patients with LRS.84 However, in our previous 
observational study it was shown that GPs did not adhere to the guideline regarding the 
referral to physical therapy (PT); almost half of patients with LRS were referred for PT, 
although this was not recommended in the guideline. No specific characteristic could be 
identified to explain this referral to PT.84 However, there is a lack of knowledge concerning 
the effectiveness of PT in LRS. Therefore, this study aimed to assess the effectiveness of PT 
management additional to GP management compared to GP management alone, in 
patients with acute LRS. 
 
Methods 
 
More detailed information about the methods of the LRS trial is presented elsewhere.114 The 
Erasmus Medical Center Ethics Committee approved the procedures and design of this 
trial. 
 
Study population 
Participating GPs in Rotterdam and the surrounding area invited patients with acute LRS to 
participate in the trial from May 2003 to November 2004. Table 1 shows the eligibility 
criteria. 
 
Table 1: Selection criteria for trial eligibility 
 
Inclusion: 
Radiating (pain) complaints in the leg below the knee 
Severity of complaints scored above 3 on an 11-point NRS (0= no complaints; 10= maximum complaints) 
Duration of the (pain) complaints less than 6 weeks 
Age between 18 and 65 years 
Able to speak and read Dutch 
Presence of one of the following symptoms: 
More pain on coughing, sneezing or straining 
Decreased muscle strength in the leg 
Sensory deficits in the leg 
Decreased reflex activity in the leg 
Positive straight leg raising test 
 
Exclusion: 
Radiating (pain) complaints in the preceding 6 months 
Back surgery in the past 3 years 
Treated with epidural injections 
Pregnancy 
Co-morbidity that determines overall well-being 
Direct indication for surgery (unbearable pain, fast progression of paresis or cauda equina syndrome) 
Expected loss to follow-up (i.e. moving to another part of the country, long-lasting foreign holiday) 
NRS: Numerical rating scale. 
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Randomisation 
A concealed randomisation procedure10 was used, which was based on a computer-
generated randomisation list developed by an independent person. In order to prevent 
unequal treatment group sizes, block randomisation was used with blocks of 10 patients.85 
The research assistant performed the randomisation after baseline measurement. 
 
Blinding 
For obvious reasons the GPs, physical therapists and patients were not blinded for 
treatment allocation. The statistical analysis and interpretation of the findings was audited 
and verified by an independent and independent statistician. 
 
GP care 
All patients were treated by the GP according to their clinical guideline.11 GPs gave 
information and advice about LRS and, if necessary, prescribed (pain) medication. 
 
Physical therapy 
PT treatment consists of exercise therapy as well as giving information and advice about 
LRS. Passive modalities such as massage and manipulation techniques, or applications such 
as ultrasound therapy or electrotherapy were not allowed. The treatment protocol was 
developed in a consensus meeting with participating physical therapists. They acted as 
coaches and guided the patient in order to stimulate return to activity, despite the pain 
experience. Both GP and PT interventions were restricted to a maximum of 9 
treatments/consultations in the first 6 weeks after randomisation. 
 
Measurements 
Collected at baseline were patients’ characteristics such as gender and date of birth. 
Standardised history taking was used to establish whether patients were familiar with LRS 
in the past, reported more pain in the leg on coughing/sneezing or straining, on sitting, 
standing, walking and lying down, and whether patients reported decreased muscle 
strength and sensory deficits in the leg. The physical examination included amongst others 
the straight leg raising test and the test of Bragard. 
 
Primary outcome measure 
The primary outcome measure was the Global Perceived Effect (GPE), measured on a 7-
point scale ranging from 1=completely recovered to 7=vastly worsened.90-92 These ratings 
were dichotomised as improved (“completely recovered” and “much improved”), versus not 
improved (“slightly improved”, “not changed”, “slightly worsened”, “much worsened” and 
“worse than ever”). 
 
Secondary outcome measures 
Pain severity of the leg and the back was scored separately on an 11-point numerical rating 
scale (NRS) ranging from 0=no pain to 10=unbearable pain.115 The functional status was 
measured with the Roland Morris Disability Questionnaire (RDQ) for sciatica.96 
Health status was measured by the 36-item short form (SF-36)101  and the Euroqol (EQ-5D) 
instrument.102,103 Fear of movement was measured by the Tampa scale for kinesiophobia 
(TSK).110,111 LRS-related absence from work (in days) and medical consumption were 
measured by means of a questionnaire. 
 
 
 Statistical analysis 
The statistical analysis was performed according to the intention-to-treat principle, 
analysing all patients in the treatment group to which they were randomly allocated. 
Baseline comparability was investigated by descriptive statistics to examine whether 
randomisation was successful. Missing (item) values were assigned the last available score. 
Group differences and 95% confidence intervals (CI) were calculated for all outcome 
measures with a baseline value. Between group differences were calculated using the 
Student’s t-test for continuous variables and the Chi-square test for dichotomous variables. 
Results are presented as relative risks (RR) or effect sizes (ES) with corresponding 95% CI. 
There was a statistical significant difference if the p-value was smaller than 0.05, and a 
clinically relevant difference when a 20% difference appeared in one of the outcome 
measurements between both groups. In addition a per-protocol analysis was performed, 
analysing only those patients with no serious treatment protocol deviations, e.g. received 
the allocated treatment. Pre-determined subgroup analyses were performed for patients 
with severe disability (RDQ >= 17). 
 
Results 
 
Study population 
In total 112 GPs participated in the trial and referred 170 patients for eligibility check. 
Excluded from the trial were 35 patients for one or more of the following reasons; 16 
patients did not want to participate, 1 patient was older than 65 years, 7 patients had (pain) 
complaints for more than 6 weeks, 3 patients had no radiating (pain) complaints in the leg 
below the knee, 5 patients were not available for follow-up measurements, 3 patients had 
back surgery in the past 3 years, 1 patient had received an epidural injection, 7 patients were 
already treated by a PT, and 2 patients were pregnant. 
 
Included and randomised were 135 patients, 67 patients received GP plus PT care (the 
intervention group), and 68 patients received GP care only (the control group). Four 
patients dropped-out immediately after randomisation because they no longer wished to 
participate, 1 in the intervention group and 3 in the control group. Figure 1 shows the flow 
chart of the trial. 
 
Characteristics of the study population 
Table 2 gives the demographic and clinical characteristics of the randomised patients. The 
two groups were considered comparable for all measured baseline characteristics. 
 
Interventions 
At 6 weeks follow-up, the 67 patients of the intervention group and 68 patients of the 
control group reported a mean GP consult of respectively 1.1 (SD: 1.5) and 1.7 (SD: 1.8), 
since baseline. The mean GP consult at 12 weeks and 52 weeks follow-up was respectively 
1.6 (SD: 1.4) and 1.8 (SD 1.9) in the intervention group and respectively 1.9 (SD: 2.1) and 
2.2 (SD 2.7) in the control group. These differences were not significant. At baseline, the 
GPs had prescribed NSAIDs, opioids, and muscle relaxants for respectively 47, 8 and 23 
patients in the intervention group, and for respectively 40, 10 and 15 patients in the control 
group. 
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Figure 1: Flow chart of the trial 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Patients in the intervention group were treated by 33 different physical therapists. The 
number of treated patients per physical therapist ranged from 1 to 9. Patients in the 
intervention group reported a mean of 6.7 (SD: 2.9) PT treatments of at 6 weeks follow-up, 
and 9.7 (SD: 4.7) at 12 weeks follow-up. The mean time between randomisation and the 
first PT treatment was 4.6 days (SD: 3.1). The physical therapists reported that during the 
first treatment 60% (range: 10-100%) of the time was spent on history taking and physical 
examination, 30% (range: 0-60%) on giving information and advice about LRS, and 10% 
(range: 0-40%) on active exercise therapy (duration of one treatment session was 30 
minutes). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
General practitioners (n=112)
Patient eligibility check (n=170)
Excluded patients (n=35)
Informed consent 
Baseline measurement
3 weeks follow-up 
Complete questionnaires (n=65) 
Last value carried forward (n=2) 
GP and PT care (n=67) GP care (n=68)
Randomisation (n=135)
6 weeks follow-up 
Complete questionnaires (n=65) 
Last value carried forward (n=2) 
3 weeks follow-up 
Complete questionnaires (n=58) 
Last value carried forward (n=10) 
12 weeks follow-up 
Complete questionnaires (n=64) 
Last value carried forward (n=3) 
52 weeks follow-up 
Complete questionnaires (n=60) 
Last value carried forward (n=7) 
6 weeks follow-up 
Complete questionnaires (n=64) 
Last value carried forward (n=4) 
12 weeks follow-up 
Complete questionnaires (n=62) 
Last value carried forward (n=6) 
52 weeks follow-up 
Complete questionnaires (n=57) 
Last value carried forward (n=11) 
 Table 2: Baseline characteristics of the 135 patients randomised in two treatment groups. 
 
Characteristics GP + PT care (n=67) GP care only (n=68) 
Female gender, n (%) 38 (57) 27 (40) 
Age in years, mean (SD) 42 (10) 43 (12) 
Paid job, n (%) 48 (72) 50 (74) 
Reporting sickness absence, n (%) 34 (51) 32 (47) 
Sickness absence from onset in days, mean (SD) 3.1 (4.9) 4.2 (6.8) 
Time between onset LRS and baseline in days, mean (SD) 12.1 (10.1) 14.2 (10.2) 
Never LRS in past, n (%) 49 (73) 54 (79) 
More pain in leg on coughing, sneezing or straining, n (%) 40 (60) 37 (54) 
Decreased muscle strength in the leg, n (%) 48 (72) 44 (65) 
Sensory deficits in the leg, n (%) 54 (81) 53 (78) 
Positive straight leg raising test, n (%) 37 (55) 35 (52) 
Positive test of Bragard, n (%) 25 (37) 23 (34) 
Taking medication, n (%) 58 (87) 48 (71) 
Leg pain on NRS&, mean (SD) 6.3 (2.2) 6.3 (2.2) 
Back pain on NRS, mean (SD) 5.8 (2.8) 5.7 (2.5) 
RDQ¢ score, mean (SD) 15.9 (4.1) 15.4 (5.0) 
TSK¥ score, mean (SD) 39.0 (5.8) 41.0 (7.1) 
& NRS=Numerical Rating Scale. Score range from 0 (no pain) to 10 (unbearable pain). 
¢ RDQ=Roland disability questionnaire. Score range from 0 (no disability) to 24 (severe disability). 
¥ TSK=Tampa scale for kinesiophobia. Scores range from 17 to 68 points; higher score indicates 
more kinesiophobia. 
 
During the second through ninth treatment, 33% (range: 0-100%) of the time was spent on 
giving information and advice, and 67% (range: 0-100%) on active exercise therapy. 
 
Outcomes 
In both groups patients improved over time. At 3, 6 and 12 weeks after baseline there was 
no significant difference between the two groups on the primary outcome: GPE (Table 3). 
However, at these follow-up moments the intervention group showed a higher proportion 
of ‘improved’ patients. 
 
Table 3: Data on treatment results at 3, 6, 12 and 52 weeks after baseline: primary outcome. 
 
 
Global perceived effect* 
GP + PT care 
Improved 
n=67 (%) 
GP care only 
Improved 
n=68 (%) 
RR (95% CI) NNT 
3 weeks after baseline 30 (45) 22 (32) 1.4 (0.9; 2.1) 8 
6 weeks after baseline 38 (60) 30 (44) 1.3 (0.9; 1.8) 8 
12 weeks after baseline 47 (70) 42 (62) 1.1 (0.9; 1.5) 12 
52 weeks after baseline 53 (79) 38 (56) 1.4 (1.1; 1.8) 4 
*: Ratings on patient’s globally perceived effect on a 7-point scale were dichotomised 
(see Methods section). 
RR: Relative risk. 
CI: Confidence interval. 
NNT: Number needed to treat. 
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At 52 weeks after baseline there was a significant and a clinical difference between the 
groups on the primary outcome measure global perceived effect, in favor of the intervention 
group (Table 3). 53 patients (79%) in the intervention group versus 38 patients (56%) in the 
control group reported to be ‘improved’ (RR, 1.4; 95% CI: 1.1; 1.8). There were no 
significant differences between the groups in most of the secondary outcomes at 3, 6, 12 and 
52 weeks after baseline (Table 4). 
 
Table 4: Data on treatment results at 3, 6, 12 and 52 weeks after baseline: secondary outcomes. 
 
 GP + PT care 
Improvement 
n=67 
GP care only 
Improvement 
n=68 
Mean difference 
[GP+PT] - [GP] 
(95% CI) 
Effect size 
(95% CI) 
3 weeks after baseline     
Leg pain on NRS & # -2.3 (2.4) -1.9 (2.4) -0.4 (-1.2; 0.4) 0.17 (-0.2; 0.5) 
Back pain on NRS & # -2.0 (2.8) -1.7 (2.4) -0.3 (-1.2; 0.6) 0.12 (-0.2; 0.5) 
6 weeks after baseline     
Leg pain on NRS & # -3.0 (2.7) -3.3 (2.8) 0.3 (-0.6; 1.2) 0.11 (-0.2; 0.5) 
Back pain on NRS & # -2.3 (3.1) -2.6 (2.7) 0.3 (-0.7; 1.3) 0.19 (-0.2; 0.5) 
RDQ score ¢ # -5.3 (7.0) -6.6 (6.1) 1.3 (-0.9; 3.6) 0.22 (-0.1; 0.5) 
General health £ # 2.2 (16.4) -2.8 (13.9) 5.0 (0.2; 10.1) 0.36 (-0.0; 0.7) 
12 weeks after baseline     
Leg pain on NRS & # -3.9 (2.8) -3.7 (3.1) -0.2 (-1.2; 0.8) 0.05 (-0.3; 0.4) 
Back pain on NRS & # -2.7 (3.2) -2.6 (2.9) -0.1 (-1.2; 0.9) 0.04 (-0.3; 0.4) 
RDQ score ¢ # -7.7 (7.3) -8.5 (6.7) 0.8 (-1.6; 3.2) 0.12 (-0.2; 0.5) 
General health £ # -1.2 (18.4) -4.7 (16.4) 3.5 (-2.4; 9.5) 0.22 (-0.1; 0.5) 
52 weeks after baseline     
Leg pain on NRS & # -4.4 (2.7) -3.7 (2.7) -0.7 (-1.7; 0.2) 0.26 (-0.1; 0.6) 
Back pain on NRS & # -3.0 (3.1) -2.3 (2.9) -0.7 (-1.7; 0.4) 0.23 (-0.1; 0.6) 
RDQ score ¢ # -10.0 (6.5) -9.1 (6.1) -0.9 (-3.0; 1.3) 0.14 (-0.2; 0.5) 
TSK score ¥ # -3.3 (7.3) -4.5 (6.6) 1.2 (-1.2; 3.6) 0.17 (-0.2; 0.5) 
General health £ # -3.1 (15.7) -4.1 (16.7) 1.0 (-4.5; 6.5) 0.06 (-0.3; 0.4) 
All outcome measures are presented in in means and standard deviation, unless otherwise stated. 
& NRS=Numerical Rating Scale. Score range from 0 (no pain) to 10 (unbearable pain). 
# Negative results denote positive results for patients. 
¢ RDQ=Roland disability questionnaire. Score range from 0 (no disability) to 24 (severe disability). 
£ Dimension of the SF-36=Short form 36 questionnaire. Score range each dimension 0-100; higher 
score indicates a better health state. 
¥ TSK=Tampa scale for kinesiophobia. Scores range from 17 to 68 points; higher score indicates more 
kinesiophobia. 
 
At 12 and 52 weeks follow-up the mean improvement on leg pain was clinically relevant in 
both groups; respectively 3.9 and 4.4 points for the intervention group and respectively 3.7 
and 3.7 points for the control group. The mean improvement on disability (RDQ) was also 
clinically relevant at 12 and 52 weeks follow-up in both groups; respectively 7.7 and 10.0 
points for the intervention group and respectively 8.5 and 9.1 points for the control group. 
 
There were no significant differences between both groups in the number of patients 
reporting absence from work or reported days absence from work. 
 At 12 weeks follow-up, 36 patients (54%) in the intervention group and 25 patients (37%) in 
the control group reported a mean of respectively 16.2 days (SD 21.3) and 13.1 days (SD 
24.1) absence from work. At 52 weeks follow-up, 30 patients (45%) in the intervention 
group and 25 patients (37%) in the control group reported, over the whole year, a mean of 
respectively 29.2 days (SD 48.4) and 28.9 days (SD 72.3) absence from work. 
 
Co-interventions 
In the 52 weeks after baseline 11 patiënts (16%) in the intervention group and 6 patients 
(9%) in the control group visited a neurologist. In the intervention group 4 patients visited a 
neurosurgeon, 1 patient a orthopedist, and 4 patients (6%) received surgery due to LRS. 
In the control group 6 patients visited a neurosurgeon, 2 patients a orthopedist, and 3 
patients (4%) received surgery. There were a few co-interventions (i.e. occupational 
physician) in both groups, but there were no significant differences between the two groups. 
 
Per-protocol analysis 
The per-protocol analysis (the patients that received the allocated treatment according 
randomisation) was restricted to 66 patients in the intervention group and 55 patients in 
the control group. Restricting the analysis to the ‘per protocol’ patients did not change the 
within group and between group differences in any substantial way. 
 
Subgroup analysis 
The subgroup with severe disability (RDQ >=17) consisted of 67 patients. The intervention 
group (n=37) and the control group (n=30) were considered comparable for all measured 
baseline characteristics. At 12 and 52 weeks follow-up, respectively 29 (78%) and 31 (84%) 
patients with severe disability in the intervention group and 15 (50%) and 16 (53%) patients 
in the control group reported to be ‘improved’ (12 weeks and 52 weeks: RR, 1.6; 95% CI, 
1.1; 2.3); indicating a significant and a clinically relevant difference. 
 
Discussion 
 
At 12 weeks after baseline there was no significant difference between both groups on the 
primary outcome, but most of the patients (70% in the intervention group and 62% in the 
control group) reported to be ‘improved’. At 52 weeks follow-up there was a significant 
(RR, 1.4; 95% CI, 1.1; 1.8) and clinically relevant difference (23%) between both groups, in 
favor of the intervention group. 
Therefore, adding PT care to GP care is more effective than GP care alone in the long-term, 
for the average patient with (sub) acute sciatica. Moreover, PT care added to GP care 
seemed to be especially effective in the subgroup with patients reporting more severe 
disability at presentation. 
 
Although the control group had 3 dropouts compared with only 1 in the intervention 
group, this did not appear to bias the results because all dropped-out immediately after 
randomisation, and results of both the per-protocol analysis and the intention-to-treat 
analysis were similar. Also, there are no indications that not blinding GPs, physical 
therapists and patients biased the results; at 12 weeks follow-up the within-group 
improvement of both groups was considerable for GPE, the leg pain on NRS and the RDQ. 
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At long-term follow-up a clinically relevant change was found on the primary outcome 
measure (GPE) between the two groups, in favor of the intervention group; the difference 
was 23%. A priori was stated that a clinically relevant difference had to be at least 20%.114 
However, recent work of Ostelo and De Vet shows the need for more research on the exact 
value for the minimal clinically important difference between two groups in this type of 
study.116 
 
A few randomised clinical trials have evaluated physical therapy as a treatment for the LRS. 
Hofstee et al. focused on bed rest, physical therapy and continuation of activities of daily 
living75; their trial included 250 patients with acute sciatica, and the authors concluded after 
a 6-month follow-up period that bed rest and physical therapy are no more effective than 
continuation of the activities of daily living.75 Coxhead et al. compared four methods of 
physical therapy (traction, exercises, manipulation and corset therapy) in 322 participating 
patients with sciatica72; the authors concluded that although active physical therapy 
appeared to be of short-term value, it did not seem to confer any long-term benefit.72 
Lidström and Zachrisson compared three methods of physical therapy (massage/exercises, 
traction and hot packs) in 62 patients with sciatica70; after treatment (one month after 
randomisation) they concluded that the traction group showed better results than the other 
two groups.70 The results of our study are not in concordance with the earlier studies, 
because we found that in the long-term PT care added to GP care is effective. The previous 
studies did not measure the absence from work (or did not report on this outcome). In the 
present study, there were no significant differences in absence from work between groups at 
short or long-term follow-up. 
 
The results of our study indicate that PT added to GP care was better for the average patient 
with a LRS than GP care alone in the long-term. Moreover, for patients with severe 
disability at presentation, PT care added to GP care seemed to be especially effective. Future 
trials are necessary to evaluate the effectiveness of physical therapy in patients with severe 
disability. 
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Abstract 
 
Objective To evaluate the cost-effectiveness of physical therapy and general practitioner care 
for patients with an acute lumbosacral radicular syndrome (LRS; also called sciatica) 
Design, setting and patients An economic evaluation alongside a randomised clinical trial in 
primary care. 135 patients were randomly allocated to physical therapy added to general 
practitioners’ care (n=67) or to general practitioners’ care alone (n=68). 
Main outcome measures The clinical outcomes were global perceived effect and quality of 
life. The direct and indirect costs were measured by means of questionnaires. The follow-up 
period was one year. The Incremental Cost Effectiveness Ratio (ICER) between both study 
arms was constructed. Confidence intervals for the ICER were calculated using Fieller’s 
method and using bootstrapping. 
Results There was a significant difference on perceived recovery at 1-year follow-up in favor 
of the physical therapy group. The additional physical therapy did not have an incremental 
effect on quality of life. At 1-year follow-up, the ICER for the total costs was € 6224 (95% 
CI: -10419; 27551) per improved patient gained. For direct costs only, the ICER was € 837 
(95% CI: -731; 3186). 
Conclusions Physical therapy provided no cost effective addition to care in general practice, 
for patients with LRS. Although, adding physical therapy resulted in more perceived 
recovery. 
 
Introduction 
 
The lumbosacral radicular syndrome (LRS), also called sciatica, is a disorder with radiating 
pain in the leg below the knee in one or more lumbar or sacral dermatomes, and can be 
accompanied by phenomena associated with nerve root tension or neurological deficits.2-5 A 
prolapsed disc is a frequent cause of LRS, but other causes include spinal or lateral recess 
stenosis, tumours and radiculitis.1,5 The incidence of LRS in the Netherlands is estimated at 
5 per 1000 persons a year.1 LRS is not life threatening, but it causes pain in the leg and 
disability, often resulting in utilisation of healthcare resources and absenteeism from work.1 
The total, direct and indirect, costs of LRS in the Netherlands are estimated at 1.18 billion 
euro a year.1 Therefore, there is a need to determine the most cost effective intervention for 
LRS. 
 
Most patients seeking medical care in the Netherlands will first visit a general practitioner 
(GP). In 1996 the Dutch College of General Practitioners published their first clinical 
guideline for LRS11 and updated it in 2005.5 There is consensus that treatment of LRS in the 
first 6 to 8 weeks should be conservative. 
 Many conservative treatments are available for treating LRS, but most patients are referred 
to physical therapy.84 The effectiveness of conservative treatments is however not yet 
clear.117 A randomised controlled trial was performed to evaluate the effectiveness of 
physical therapy added to general practitioner care compared to general practitioner care 
alone in patients with acute LRS.114 The clinical effects at 1-year follow-up has been 
reported elsewhere.118 This study aimed to assess the cost-effectiveness of physical therapy 
and general practitioner care for patients with acute LRS. 
 
Methods 
 
More detailed information about the methods of the LRS trial is presented elsewhere.114 The 
Erasmus Medical Center Ethics Committee approved the procedures and design of this 
trial. 
 
Study population 
Participating GPs (n=112) in Rotterdam and the surrounding area invited patients with 
acute LRS to participate in the trial from May 2003 to November 2004. Table 1 shows the 
eligibility criteria. 
 
Table 1: Selection criteria for trial eligibility 
 
Inclusion: 
Radiating (pain) complaints in the leg below the knee 
Severity of complaints scored above 3 on an 11-point NRS (0= no complaints; 10= maximum complaints) 
Duration of the (pain) complaints less than 6 weeks 
Age between 18 and 65 years 
Able to speak and read Dutch 
Presence of one of the following symptoms: 
More pain on coughing, sneezing or straining 
Decreased muscle strength in the leg 
Sensory deficits in the leg 
Decreased reflex activity in the leg 
Positive straight leg raising test 
 
Exclusion: 
Radiating (pain) complaints in the preceding 6 months 
Back surgery in the past 3 years 
Treated with epidural injections 
Pregnancy 
Co-morbidity that determines overall well-being 
Direct indication for surgery (unbearable pain, fast progression of paresis or cauda equina syndrome) 
Expected loss to follow-up (i.e. moving to another part of the country, long-lasting foreign holiday) 
NRS: Numerical rating scale. 
 
Randomisation 
A concealed randomisation procedure was used, which was based on a computer-generated 
randomisation list developed by an independent person. 
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In order to prevent unequal treatment group sizes, block randomisation was used with 
blocks of 10 patients.85 The research assistant performed the randomisation after baseline 
measurement. 
 
Blinding 
For obvious reasons the GPs, physical therapists and patients were not blinded for 
treatment allocation. The statistical analysis and interpretation of the findings was audited 
and verified by an independent and uninvolved statistician. 
 
GP care 
All patients were treated by the GP according to their clinical guideline.11 GPs gave 
information and advice about LRS and, if necessary, they prescribed (pain) medication. 
 
Physical therapy 
The treatment consists of exercise therapy as well as giving information and advice about 
LRS. Passive modalities such as massage and manipulation techniques, or applications such 
as ultrasound therapy or electrotherapy were not allowed. The treatment protocol was 
developed in a consensus meeting with participating physical therapists (n=61). They acted 
as coaches and guided the patient in order to stimulate return to activity. Both GP and 
physical therapy interventions were restricted to a maximum of 9 treatments or 
consultations in the first 6 weeks after randomisation. 
 
Measurements 
The primary outcome measure was global perceived effect (GPE), measured on a 7-point 
scale ranging from 1=completely recovered to 7=vastly worsened.90-92 These ratings were 
dichotomised as improved (“completely recovered” and “much improved”), versus not 
improved (“slightly improved”, “not changed”, “slightly worsened”, “much worsened” and 
“worse than ever”). GPE was rated as the percentage of patients that reported to be 
‘improved’. The Euroqol (EQ-5D) instrument was used to calculate utilities.119,120 The 
outcome measures and costs were assessed at baseline and cumulative at 3, 6, 12, 52 weeks 
after randomisation using questionnaires. The economic evaluation was performed from a 
societal perspective, meaning that all relevant costs and effects are measured regardless of 
who pays the costs and who benefits from the effects. Table 2 shows an overview of the costs 
used in the economic evaluation.  
 Table 2: Overview unit costs in the economic evaluation. 
 
Costs Cost (€) # 
Direct health care costs:  
Physical therapy (per visit) 22.75 
General practitioner (per visit) 20.20 
Manual therapy (per visit) 25.90 
Cesar or Mensendieck therapy (per visit) 23.00 
Consultation specialist in hospital (per visit) 56.00 
Hospitalisation (per day) 337.00 
Surgery due to sciatica (laminectomie) 1149.94 
Direct nonhealth care costs:  
Help in housekeeping (per hour) 8.30 
Indirect costs:  
Absence from paid work (per hour) & 34.98 
#: Price according to Dutch guidelines121 or according to professional association (2005). 
&: Because we were only interested in the extent of productivity costs, used was an overall mean  
income per hour regardless age or gender. 
 
The direct health care costs were: costs of physical therapy, general practitioners care, 
medication, addition visits to other healthcare providers and hospitalisation. Direct 
nonhealth care costs were: costs of devices, out of pocket expenses and costs of help in 
housekeeping. Indirect costs outside the health care system were the costs of production 
losses caused by absence from work. The costs for paid work were calculated by using the 
friction cost approach (friction period 154 days) based on the overall mean income of the 
Dutch population.121 
 
Statistical analysis 
The statistical analysis was performed according to the intention-to-treat principle, 
analysing all patients in the treatment group to which they were randomly allocated. 
Missing (item) values were assigned the last available score.  
Differences in resource utilization between the two arms were assessed. Costs were 
calculated by multiplication of each unit of resource use by its unit price. A comparison in 
resource use between the arms will provide insight in major cost drivers. Dealing with the 
nonnormality of the cost data a nonparametric test (Mann-Whitney/Wilcoxon) can be 
used.122 The Incremental Cost Effectiveness Ratio (ICER) on total costs and direct costs only 
between both study arms was constructed. Confidence intervals for the ICER were 
calculated using Fieller’s method123 (parametric approach) and using bootstrapping (non-
parametric approach) and graphically presented on the cost effectiveness plane. 
Furthermore, a cost effectiveness acceptability curve was constructed.124 The acceptability 
curve shows the probability that a treatment is cost effective at a specific ceiling ratio.122 No 
sensitivity analysis was undertaken, as most variations in cost or health effect were included 
in the bootstrap estimates of the ICER. 
 
Results 
 
Included and randomised were 135 patients, 67 patients received GP care plus physical 
therapy (the intervention group), and 68 patients received GP care only (the control group). 
Figure 1 shows the flow chart of the trial. 
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Patients referred by GP (n=170)
Not eligible patients (n=35): 
- No permission (n=16) 
- Older than 65 years (n=1) 
- Complaints more than 6 weeks (n=7) 
- No radiating complaints below the knee (n=3) 
- Not available for follow-up (n=5) 
- Back surgery in past 3 years (n=3) 
- Epidural injection (n=1) 
- Already treated by physical therapist (n=7) 
- Pregnant (n=2) 
GP and PT care (n=67) GP care (n=68)
Randomisation (n=135)
1-year follow-up 
Complete questionnaires (n=60) 
Last value carried forward (n=7) 
1-year follow-up 
Complete questionnaires (n=57) 
Last value carried forward (n=11) 
Four patients dropped-out immediately after randomisation because they no longer wished 
to participate, 1 in the intervention group and 3 in the control group. At 1 year follow-up 
117 patients (87%) completed their questionnaire, which included the cost data. Table 3 
shows the baseline characteristics of the randomised patients. 
 
Figure 1: Flow chart of the trial. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The two groups were considered similar for all measured baseline characteristics. Therefore, 
presented are only the unadjusted differences between the intervention and control 
group.118 
Table 3: Baseline characteristics of the 135 patients randomised in two treatment groups. 
 
Characteristics GP + PT care (n=67) GP care only (n=68) 
Female gender (n, %) 38 (57) 27 (40) 
Age in years (mean, SD): 42 (10) 43 (12) 
Paid job (n, %) 48 (72) 50 (74) 
Reporting sickness absence (n, %) 34 (51) 32 (47) 
Sickness absence from onset in days (mean, SD) $ 3.1 (4.9) 4.2 (6.8) 
Time between onset LRS and baseline in days (mean, SD) 12.1 (10.1) 14.2 (10.2) 
Never LRS in past (n, %) 49 (73) 54 (79) 
Taking medication for LRS(n, %) 58 (87) 48 (71) 
EQ-5D index score (mean, SD) 0.39 (0.35) 0.41 (0.35) 
$: Before randomisation. 
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Health effect of additional physical therapy 
After 1 year, there was a significant and a clinically relevant difference between the groups, 
on primary outcome (GPE) in favor of the intervention group.118 Table 4 shows that in the 
intervention group 53 of 67 patients (79%) and 38 of 68 patients (56%) in the control group 
reported to be ‘improved’ (RR, 1.4; 95% CI: 1.1; 1.8). 
 
Table 4: Data on GPE and utility at 3, 6, 12 and 52 weeks follow-up. 
 
 Baseline 3 weeks 6 weeks 12 weeks 52 weeks 
GP + PT care (n=67)      
Perceived effect *: Improved (%) -- n=30 (45) n=38 (60) n=47 (70) n=53 (79) 
Utility &, mean (SD) 0.39 (0.35) -- 0.59 (0.34)+ 0.65 (0.33) 0.76 (0.25) 
GP care only (n=68)      
Perceived effect *: Improved (%) -- n=22 (32) n=30 (44) n=42 (62) n=38 (56) 
Utility &, mean (SD) 0.41 (0.35) -- 0.70 (0.26)+ 0.73 (0.30) 0.73 (0.27) 
*: Ratings on patient’s globally perceived effect on a 7-point scale were dichotomised (see Methods section). 
&: Utility measured with Euroqol: EQ-5D index score; not measured at 3 weeks follow-up. 
+: Statistically significant difference in favor of GP care only group (P = 0.049) 
 
At baseline and at 6 and 12 weeks follow-up, the mean of the utility was higher in the 
control group and at 6 weeks follow-up statistically significant different, in favor of the 
control group (Table 4). At 1-year follow-up, the utility in the intervention group was 
higher. Figure 2 shows the mean utility for the intervention and control group at baseline 
and at 6, 12 and 52 weeks follow-up. 
 
Figure 2: Mean utility at baseline and at 6, 12 and 52 weeks follow-up. 
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Calculating QALYs for the groups, showed more QALYs for the control group (mean 0.70, 
SD 0.25) than the intervention group (mean 0.67, SD 0.26), but this was no statistically 
significant difference. 
 
Healthcare utilisation and absence from work 
During the 1-year follow-up 11 patients (16%) in the intervention group and 6 patients 
(9%) in the control group visited a neurologist. In the intervention group 4 patients (6%) 
visited a neurosurgeon, 1 patient (2%) an orthopedic surgeon, and 4 patients (6%) received 
surgery due to LRS. In the control group 5 patients (7%) visited a neurosurgeon, 2 patients 
(3%) an orthopedic surgeon, and 3 patients (4%) received surgery. At 1-year follow-up, 30 
patients (45%) in the intervention group reported a mean of 29.2 days (SD 48.4) absence 
from work and 25 patients (37%) in the control group reported a mean of 28.9 days (SD 
72.3). These were not statistically significant differences. 
 
Costs 
Table 5 shows the direct and indirect costs from the intervention and control group at 1-
year follow-up. The total direct and indirect costs consisted mainly of production losses. At 
3, 6, 12 and 52 weeks follow-up there were significant differences between groups on costs 
for physical therapy visits, in favor of the control group. The total direct and indirect costs 
were also statistically significant different at the 4 follow-up moments, in favor of the 
control group. 
 
Economic evaluation 
Because the additional PT resulted in a statistically significant higher proportion of patient 
recovered a cost effectiveness analysis with GPE, the primary outcome measure, was 
performed.  The cost effectiveness analysis was conducted twice, one time taking only the 
direct costs into account and one time using total costs, i.e. including direct and 
productivity costs. 
 
Table 5:Cumulative mean direct and indirect costs per patient in euro (€) at 3, 6, 12 and 52 weeks follow-up. 
 
 3 weeks 6 weeks 12 weeks 52 weeks 
GP + PT care (n=67)     
Direct costs     
General practitioner 13.6 (18.1) 23.2 (30.5) 33.2 (28.3) 36.2 (37.3) 
Physical therapy 87.3 (52.2)+ 139.6 (77.6) + 191.8 (125.2) + 241.4 (328.4) + 
Manual therapy 2.7 (15.7) 3.5 (20.1) 10.8 (57.4) 35.2 (128.8) 
Cesar or Mensendieck therapy 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 14.1 (83.8) 
Neurologist in hospital 4.2 (14.8) 6.7 (26.7) 9.2 (26.9) 26.7 (77.0) 
Neurosurgeon in hospital 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 7.5 (32.2) 
Orthopedic surgeon in hospital 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 1.7 (13.7) 
Hospitalisation 5.0 (41.2) 5.0 (41.2) 5.0 (41.2) 135.8 (531.4) 
Surgery due to sciatica 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 68.7 (274.5) 
Medication for sciatica 13.3 (13.2) 31.0 (30.1) 50.7 (50.9) 74.9 (73.7) 
Nonhealth care 4.1 (17.1) 5.3 (20.8) 8.5 (39.3) 12.3 (51.7) 
Total direct costs 127.5 (90.7) + 210.7 (132.2) + 293.3 (165.9) + 619.3 (899.3) + 
Indirect costs     
Production losses 1281.4 (1590.9) 2127.1 (2577.2) 3245.9 (4252.5) 5629.6 (9048.9) 
Total direct and indirect costs 1408.9 (1616.8) + 2337.8 (2616.9) + 3539.2 (4320.8) + 6248.9 (9602.5) + 
  3 weeks 6 weeks 12 weeks 52 weeks 
GP care only (n=68)     
Direct costs     
General practitioner 25.0 (22.6) 33.9 (36.3) 38.9 (43.2) 44.6 (54.1) 
Physical therapy 9.4 (28.4) + 18.1 (45.4) + 30.8 (80.1) + 76.9 (187.6) + 
Manual therapy 1.9 (11.2) 1.5 (8.8) 12.2 (85.5) 10.7 (47.0) 
Cesar or Mensendieck therapy 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 12.5 (65.8) 
Neurologist in hospital 2.5 (11.6) 5.8 (19.7) 5.8 (21.9) 13.2 (44.5) 
Neurosurgeon in hospital 0.0 (0.0) 0.8 (6.8) 3.3 (21.4) 3.3 (13.3) 
Orthopedic surgeon in hospital 0.0 (0.0) 0.0 (0.0) 1.6 (9.5) 2.5 (15.1) 
Hospitalisation 0.0 (0.0) 54.5 (410.1) 74.3 (454.2) 148.7 (718.7) 
Surgery due to sciatica 0.0 (0.0) 0.0 (0.0) 16.9 (139.5) 50.7 (237.9)) 
Medication for sciatica 11.4 (16.2) 24.9 (34.0) 40.9 (54.1) 62.0 (81.2) 
Nonhealth care 5.3 (16.8) 5.5 (19.4) 7.2 (29.9) 10.7 (55.6) 
Total direct costs 53.4 (45.4) + 143.5 (435.4) + 219.7 (616.8) + 425.1 (1043.3) + 
Indirect costs     
Production losses 1196.4 (1756.4) 1728.4 (2696.8) 2613.2 (4826.1) 4379.8 (9060.1) 
Total direct and indirect costs 1249.8 (1772.8) + 1871.9 (2846.5) + 2832.9 (5179.8) + 4804.9 (9803.2) + 
All costs presented in in means and standard deviation, 
+: Statistically significant difference in favor of GP care only group (Mann-whitney test; P < 0.05) 
 
In table 6, point estimates for the ICERs are shown. The health effect was expressed in 
patient improved (GPE) gained. Confidence intervals for the ICER were calculated using 
Fieller’s method.123 
 
Table 6: ICER and 95% confidence interval (parametric approach). 
 
 ICER 95% confidence interval 
(Fieller method) 
Additional costs (€) per patient improved gained (direct costs) 837 -732; 3186 
Additional costs (€) per patient improved gained (total costs) 6224 -10419; 27551 
 
The ICER for the direct costs only was € 837 per improved patient gained. This means that 
for every extra patient in the intervention group that reported to be ‘improved’ the extra 
direct costs were € 837. The ICER for the total costs was € 6224 per patient improved 
gained. 
 
In the statistical analysis, besides the calculation of parametric confidence intervals, a 
bootstrap procedure was performed. In such procedure, a random sample with replacement 
is taken from the original sample of patients, for both groups, with a size equal to the 
original sample size. For such bootstrap sample, again additional costs and effects and the 
ICER may be calculated. By repeating this procedure many times (here 2,500), the 
uncertainty around the ICER can be assessed. For instance, each pair of additional costs and 
additional effects, can be displayed in a scatter diagram (Figure 3). The ICER and 95% 
confidence interval estimated with the bootstrap procedure were similar to the results of the 
parametric approach presented in table 6. 
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Figure 3: Scatter diagram of bootstrapped additional direct costs and effects. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
With the outcomes of the bootstrap procedure, a so-called cost effectiveness acceptability 
curve was constructed (Figure 4). 
 
Figure 4: Acceptability curve presenting, for each possible threshold on the ICER, the probability that the ICER is 
acceptable. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This curve shows for every threshold value society may define for the ICER, the probability 
that the ICER is below that limit. When we assume a threshold of € 600 direct costs per 
patient improved gained as acceptable, the ICER is acceptable with 35% certainty. 
When we assume a threshold of € 1200 per patient improved gained as acceptable, the ICER 
is acceptable with 69% certainty. 
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 In case total costs are used, we have to assume a threshold of € 4000 and € 12000 
respectively per patient improved gained as acceptable, to consider the ICER acceptable 
with 37% and 68% certainty (C/E-acceptability curve using total costs not shown). 
We refrained from cost utility analysis because there was no effect on quality of life between 
the two groups together with higher costs for the intervention group. 
 
Discussion 
 
An economic evaluation was performed alongside a randomised clinical trial identifying the 
most efficient intervention for patients with LRS in primary care. Physical therapy added to 
general practitioners’ care resulted in more perceived recovery than the general 
practitioners’ care alone. However, the direct and indirect costs for the intervention group 
were higher than in the control group. If decision makers value additional perceived 
recovery at much less than € 6244, general practitioners care alone is probably the best 
strategy. If their valuation lies between € 6244 and € 12000, physical therapy added to 
general practitioners care is likely to be the best treatment for patients with LRS. Overall, 
this study showed that physical therapy provided no cost effective addition to care in 
general practice, for patients with LRS 
 
The total costs were dominated by productivity losses; the direct costs by the costs of 
physical therapy. This means that treating patients with physical therapy, as expected, 
resulted in more utilisation of physical therapy. But, could also mean that physical therapy 
as treatment affected absence from work and therefore productivity costs. In spite of this, 
an active treatment approach by physical therapists resulted in more perceived recovery in 
patients with LRS than general practitioners’ care alone.118 
 
In terms of QALYs gained the additional physical therapy showed no health effect. To 
calculate QALYs patients were asked to complete EQ-5D at baseline and 6, 12 and 52 weeks 
follow-up. EQ-5D is a generic preference-based measure of health. The results of our study 
suggest that this instrument is not sensitive enough to capture the health effects of the 
additional physical therapy. Therefore, the cost effectiveness of additional physical therapy 
was assessed using GPE as the health outcome measure. 
 
Waiting times are expected to influence costs, health effects and cost-effectiveness of health 
care.125 In our study the waiting time for health care utilisation was unknown. The 
economic evaluation performed, ignored waiting time for health care utilisation and this 
might have biased the cost-effectiveness results. Moreover, it is very reasonable that this 
waiting time affected absence from work and therefore productivity costs. In future studies 
there should be paid more attention to analysing the impact of waiting time on absence 
from work and costs effects. 
 
The measurements of the direct and indirect costs were cumulative at the follow-up 
moments. Therefore, recall bias in patients could have occurred because we asked for the 
direct and indirect costs from baseline to the follow-up moment. It is more precise and 
uniform to measure costs according methods described in the handbook for cost studies 
from Oostenbrink et al.121 
Nevertheless, the patients were randomised in two groups, therefore, we suggest that the 
between group conclusion about cost effectiveness was not affected very much. 
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As far as known, no full economic evaluation alongside a randomised clinical trial that 
involved patients with LRS treated by physical therapy has yet been published. Our 
economic evaluation showed ICERs of € 837 (direct costs) and € 6224 (total costs) per 
improved patient gained. Therefore, in the treatment of patients with LRS, physical therapy 
added to general practitioners’ care is not more cost-effective than general practitioners’ 
care alone, but significant more patients reported perceived recovery. 
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General discussion 
 
 
Providers of health care are constantly aiming to provide their patients with the best 
possible treatment. Currently, the most efficient tools available for healthcare givers are 
clinical guidelines. These guidelines generally recommend diagnosis and treatment options 
that are, as much as possible, based on the available scientific (published) evidence within a 
certain time frame. When patients are treated according to such guidelines, this is called 
evidence-based practice. 
 
The research described in this thesis focused on the conservative treatment of patients with 
the lumbrosacral radicular syndrome (LRS). As reported in the General Introduction many 
(para)medical professions are involved in the conservative treatment of LRS, for which 
there are currently two guidelines available in the Netherlands. One guideline for LRS 
(issued in 1995 by the Dutch Institute of Quality Health Care) contains consensus 
recommendations established by 12 (para)medical specialties (Chapter 3). Only one 
healthcare profession, the general practitioners (GPs), has its ‘own’ guideline for LRS 
(issued in 1996 and updated in 2005). 
 
As reported in Chapter 1, GPs followed their clinical guideline for patients with LRS to a 
great extent with regard to history taking, physical examination, diagnosing and 
treatment(s). When they did deviate from the recommendations of the guideline, this was 
because of evidence-based knowledge that had recently become available. It is indeed 
possible that new evidence becomes available during the time period in which guidelines 
are updated. Currently, with ever-faster computers and Internet connections, access to the 
scientific literature has increased enormously. Therefore, caregivers can rapidly implement 
the latest evidence into their daily practice, which at that time may outdate the guideline. 
For example, in the GP guideline of LRS issued in 1996, bed rest is a treatment option. In 
1999 to 2000 data were published showing a lack of efficacy regarding bed rest in the 
treatment of patients with LRS.17,46 As reported in Chapter 1, GPs already implemented this 
knowledge (i.e. no prescription of bed rest) in their daily practice before the guideline was 
updated. 
The GP guideline of 199611 also stated that physical therapy was not a treatment option 
because the efficacy had not been demonstrated. In spite of this, GPs referred 49% of their 
patients with LRS to physical therapy (Chapter 1). In the updated GP guideline (2005)5 
physical therapy is recommended for those patients with LRS who need a more active 
approach than a GP can offer. Therefore, it is very important to frequently update the LRS 
guidelines, especially if new evidence may lead to changes in the recommendations.21 
 
Neurosurgeons in the Netherlands do not have their ‘own’ guideline for LRS. In the 
Netherlands we estimate - that since 1988 - about 10,000 patients undergo surgery each year 
due to LRS.23 In this respect, it should be noted that the surgical rate in the Netherlands is 
relatively high compared to other western countries.24 Six times as many lumbar 
discectomies are performed compared to Scotland, 4 times the number in England, and 2 
times the number performed in Sweden. Only in the USA were more operations performed 
for LRS than in the Netherlands. 
 
 The findings in this thesis (Chapters 2 and 3) show that neurosurgeons subscribed to and 
followed the recommendations as stated in the multidisciplinary LRS guideline (1996).2 
Despite this, there are no indications that the surgical rate has changed over the years since 
1996. This could mean that the (high) surgical rate reflected and still reflects good clinical 
practice.126 
 
In Chapter 4 we reported the 19-month follow-up data of patients with LRS who had 
undergone surgery. It appeared that 63% of these patients still reported LRS complaints 
after a 19-month period. The (cost) effectiveness of surgery in patients with LRS has not yet 
been established. There is one prospective low-quality study included in the systematic 
review (Chapter 5) that evaluated surgery compared with a conservative treatment.25 From 
the systematic review (Chapter 5) we concluded that there is only limited evidence that 
surgery is more effective for patients with LRS regarding improvement compared to 
physical therapy at 1-year follow-up.25 At 4 and 10-years follow-up no difference regarding 
overall improvement between surgery and physical therapy has been found.25 
In Chapter 4 we report that the median time between the first visit to the neurosurgeon and 
surgery was 6 weeks (IQR 9). Although there is consensus that surgery should be offered in 
case of persistent pain, the timing of surgery seems to depend on local production capacity 
and on the preferences of the patients and neurosurgeons rather than on evidence-based 
practice. This lack of evidence for the timing of surgery after the 6 to 8 weeks conservative 
treatment period could explain the large variations in daily practice. The results of an 
ongoing high-quality study of Peul et al.126 evaluating the (cost) effectiveness and timing of 
surgery in patients with LRS will contribute data to counteract this lack of evidence. 
 
To gain insight into the available evidence on the effectiveness of conservative treatment 
regarding LRS, we performed a systematic review of the literature (Chapter 5). We used the 
methods as recommended by the Cochrane Collaboration Back Review Group47 for 
transparency and comparability with other systematic reviews in this field. Only 
randomised clinical trials were included, because these provide the best evidence on the 
effectiveness of interventions. The 30 publications included in the review were, however, 
very heterogeneous, especially with respect to the duration of the LRS, (control) 
treatment(s), length of follow-up, and outcome measures. Therefore, a qualitative analysis 
was performed, using the five levels of evidence rather than a quantitative meta-analysis.47 
Strikingly, almost all of the studies in this review reported no differences in outcomes 
between the intervention and control group. So, as a consequence, we do not recommend 
clinicians to use corticosteroid injections or traction therapy in the treatment of patients 
with LRS, as in several trials no clear evidence of a positive effect could be found. Whether 
clinicians should prescribe physical therapy, bed rest, manipulation or medication could 
not be concluded from this review. In the updated GP guideline of LRS5 (2005) the 
recommendations regarding conservative treatment are in concordance with the results of 
our systematic review.  
 
Whilst conducting the review the question arose as to how many trials are required or, in 
other words, how strong does the evidence need to be, to allow the conclusion that a 
treatment is not effective or should not be recommended as a treatment option. For 
example, regarding injection therapy, 14 trials were included of which 4 trials (1 high and 3 
low-quality studies) reported significant differences between groups whereas 10 trials (6 
high and 4 low-quality studies) did not. 
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Based on these findings we decided not to recommend injection therapy as a treatment 
option for patients with LRS. However, there is no consensus, in general, on how to weigh 
this evidence. 
Recently, the Grading of Recommendations, Assessment, Development, and Evaluation 
(GRADE) working group developed a new system for rating evidence; this system is simple 
to use and applicable to a wide variety of recommendations spanning the full spectrum of 
medical specialties and clinical care.127 
 
Applying the GRADE classification to the injection therapy in LRS, we should conclude 
that there is a high degree of evidence that further research is most unlikely to change the 
estimated effect. Therefore, our conclusions regarding injection therapy are in line with the 
rating system of the GRADE working group. 
 
A pragmatic randomised clinical trial in primary care was performed to assess the 
effectiveness of physical therapy in addition to GP care, in patients with acute LRS (Chapter 
7). It was concluded that physical therapy is more effective in the treatment of patients with 
acute LRS than GP care alone. 
In this trial the sample size of 135 randomised patients was somewhat lower than the 182 
patients that were aimed for. In spite of this, the results show a clinically relevant difference 
of 23% in primary outcome between groups in favour of the physical therapy group at 12 
months follow-up. The dropout rate and loss to follow-up at follow-up measurements were 
generally acceptable. In the literature no clear prognostic factors have been reported that 
influence the response to physical therapy or GPs’ care. Thus, no arguments were found to 
exclude particular subtypes of LRS, to pre-stratify on particular baseline characteristics, or 
to make the study population more homogeneous. 
In this pragmatic trial, it was impossible to perform blinding on patient and on caregiver 
level. This may have produced some bias, because knowledge of the type of treatment 
received may influence the response to that treatment. It was assumed hat GPs followed 
their clinical LRS guideline11, and that physical therapists gave exercise therapy as well as 
information and advice about LRS. 
The intention-to-treat analysis showed that at 12-months follow-up there was a significant 
health effect in the primary outcome (i.e. patients’ global perceived effect) in favour of the 
physical therapy group. However, at 3, 6 and 12 weeks follow-up there were no significant 
differences between the groups either in primary outcome or in secondary outcomes. We 
can only hypothesize why a significant health effect was only found after 12-months follow-
up. One reason could be that patients with LRS, who do not have a favourable natural 
course in the first 3 to 6 months, benefit significantly on the long term from the physical 
therapy received in a relatively early stage. This could be due to better coping strategies with 
the LRS complaints learned through physical therapy. Another reason could be that we did 
not have enough ‘power’ in the trial to reach statistically significant differences, because we 
aimed to enrol 182 patients (Chapter 6) but finally randomised only 135 patients. On the 
other hand, the subgroup analysis in patients with severe disability at baseline indicated a 
significant difference in perceived recovery at 3 and 12 months follow-up in favour of the 
physical therapy group. 
 
The economic evaluation in Chapter 8 showed that the physical therapy provided may not 
be a cost-effective addition to care in general practice, for patients with LRS. The higher 
costs in the physical therapy group were mainly due to the direct costs of the physical 
therapy sessions. 
 It appeared that more absenteeism from work was an adverse event of the intervention 
group, although this difference was not significant compared with the control group. The 
policymakers should decide how to value the additional perceived recovery achieved with 
physical therapy. If they value the additional perceived recovery at much less than € 6,244, 
then the GPs’ care alone is probably the best strategy. If their valuation lies between € 6,244 
and € 12,000, then the physical therapy in addition to the GPs’ care is likely to be the best 
treatment for patients with LRS. 
 
Overall it can be concluded that, regarding the GP guideline for LRS5, our research results 
contribute to the scientific evidence for the underlying recommendation that patients with 
LRS could be referred to physical therapy with an active treatment program, particularly for 
those patients suffering severe disability at presentation. This could be included in the next 
update of the GP guideline. The perceived extra recovery has its price, as we calculated in 
the cost-effectiveness analyses. Policymakers need to decide whether or not these extra costs 
are acceptable. Furthermore, it is advised that more professions dealing with LRS patients 
should develop their own clinical guidelines, especially the physical therapists and 
neurosurgeons, in order to perform transparent, evidence-based practice. 
 
Suggestions for future research regarding LRS 
 
Guidelines 
The research conducted in this thesis mainly concerned the GPs’ and neurosurgeons’ 
management of patients with LRS. To obtain a full picture of adherence to LRS guidelines, 
future studies should also involve physical therapists, neurologists, orthopedic surgeons and 
rehabilitation physicians. 
 
Physical therapy 
It would be interesting to conduct a follow-up lasting two years or more of the patients 
randomised in the trial described in Chapter 7, to establish whether the delayed effect in 
perceived recovery in the physical therapy group persists over time. 
 
Neurosurgeons 
Chapter 4 describes the mid-long-term outcomes after surgery in patients with LRS. A 
substantial part of the patients reported LRS-related complaints at 19 months after surgery. 
More research about the (cost) effectiveness of surgery due to LRS and the timing of surgery 
is required. 
 
Additional research 
There is conflicting evidence as to whether corticosteroid injection could play a role in 
short-term pain relief. Also the (long-term) effects of traction, bed rest, manipulation and 
medication are largely unknown. For these topics we recommend high-quality randomised 
clinical trials of sufficient sample size with long-term follow-up (up to two years or more). 
The outcome measures should include overall improvement, patients’ satisfaction, severity 
of pain in the leg, functional health status, quality of life status, return to work, and adverse 
reactions. 
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Summary 
 
 
The lumbosacral radicular syndrome causes pain in the leg and disability, often resulting in 
utilisation of healthcare resources and absenteeism from work. In general practice this 
syndrome is the most frequently seen specific low-back disorder. The aim of the research 
described in this thesis was to establish general practitioners’ and neurosurgeons’ current 
management of patients with a lumbosacral radicular syndrome compared with their 
guidelines, and to assess the (cost) effectiveness of physical therapy in addition to the 
general practitioners’ care, in patients with an acute lumbosacral radicular syndrome. 
 
Chapter 1 reports a survey that investigated the current treatment policy of general 
practitioners in patients with a lumbosacral radicular syndrome compared with their 
clinical guideline. Sixty-three general practitioners completed questionnaires about their 
treatment policy in individual patients with a lumbosacral radicular syndrome at baseline 
and at 6-months follow-up. Simultaneously, 136 patients of these general practitioners were 
interviewed at baseline, and at 3 and 6-months follow-up. Of the 12 recommendations in 
the guideline related to history taking, four were not adhered to by the general practitioners 
in about 25% of the patients. Of the 10 recommended physical examinations, three were not 
frequently carried out by the general practitioners. Almost 40% of the patients were referred 
to physiotherapy and 27% received muscle relaxants. It was concluded that the majority of 
the general practitioners support the content of the lumbosacral radicular syndrome 
guideline. Overall, there was a good adherence with the guideline for history taking and 
physical examination, and a moderate adherence for treatment policy. 
 
Chapter 2 presents a survey of the opinion of neurosurgeons on the multidisciplinary 
clinical guideline ‘lumbosacral radicular syndrome’. The aim was to describe to what extent 
neurosurgeons in the Netherlands endorse the content of this guideline. The guideline was 
issued in 1996 by the Netherlands Institute of Quality Health Care and this is the first 
attempt to evaluate the implementation of this guideline. All active neurosurgeons in the 
Netherlands (n=92) were invited to complete a questionnaire investigating to what extent 
they agree with the 26 recommendations in the guideline ‘lumbosacral radicular syndrome’. 
Overall, 75% of the neurosurgeons responded and, of these, 94% agreed (at least partially) 
with the content of the guideline. Of the 26 recommendations in the guideline, seven were 
not fully endorsed by the neurosurgeons. This survey showed that almost all neurosurgeons 
subscribed (at least partially) to the multidisciplinary lumbosacral radicular syndrome 
guideline. Therefore, one important aspect of the implementation process has been fulfilled, 
i.e. acceptance of the content of the guideline. 
 
In Chapter 3 we present a survey that established to what extent neurosurgeons subscribe 
to the lumbosacral radicular syndrome guideline, and also evaluated their current 
management of patients with a lumbosacral radicular syndrome against this guideline. All 
active neurosurgeons in the Netherlands (n=92) were mailed a questionnaire about the 
guideline and data from 66 responders were analysed. Patients were recruited via seven of 
the participating neurosurgeons and were interviewed once by telephone. The medical 
records of the participating patients (n=163) were also examined. 
Of the 26 propositions in the lumbosacral radicular syndrome guideline, seven are not fully 
endorsed by the neurosurgeons. 
 Three of these seven propositions may need updating based on ‘new evidence’. The time 
between the onset of the lumbosacral radicular syndrome episode and the actual moment of 
surgery was considerably longer than that recommended in the guideline. It was concluded 
that, based on their current management of patients with a lumbosacral radicular 
syndrome, the neurosurgeons largely adhere with the guideline. 
 
In Chapter 4 we determined the mid-long-term outcomes after surgery in patients with a 
lumbosacral radicular syndrome and identified prognostic factors for persisting 
lumbosacral radicular syndrome symptoms. A total of 250 consecutive patients operated on 
by seven neurosurgeons in four hospitals between May and December 2001 were selected 
from medical records. They were asked to take part in a telephone questionnaire at 6 and 19 
months after operation. All patients had undergone discectomy for lumbosacral radicular 
syndrome at L4-L4 or L5-S1 and were aged from 18 to 65 years. Of the 250 patients, 163 
participated in the study: 63% reported they still had lumbosacral radicular syndrome 
related complaints 19 months after surgery. However, severe leg pain had decreased in 83% 
of the patients. In general the patients were satisfied with their treatment. Female gender 
and an age of 51-65 years were prognostic factors for persistent LRS symptoms. It was 
concluded that more than half of the patients reported lumbosacral radicular syndrome 
related complaints 19 months after surgery. 
 
Chapter 5 presents a systematic review that assessed the effectiveness of conservative 
treatments of the lumbosacral radicular syndrome. A search was made in relevant electronic 
databases and in the reference lists of articles up to May 2004. Included were randomised 
clinical trials of all types of conservative treatments for patients with the lumbosacral 
radicular syndrome selected by two reviewers. Two other reviewers independently assessed 
the methodological quality and the clinical relevance. Because the trials were considered 
heterogeneous we decided not to perform a meta-analysis but to summarise the results 
using the rating system of levels of evidence. Thirty trials were included that evaluated 
injections, traction, physical therapy, bed rest, manipulation, medication, and acupuncture 
as a treatment for the lumbosacral radicular syndrome. It was concluded not to recommend 
corticosteroid injections and traction as a treatment option because several trials indicated 
no evidence of an effect. Whether clinicians should prescribe physical therapy, bed rest, 
manipulation or medication could not be concluded from this review. At present there is no 
evidence that one type of treatment is clearly superior to others (including no treatment) 
for patients with a lumbosacral radicular syndrome. 
 
Chapter 6 presents the design of a randomised clinical trial that investigated the 
effectiveness of physical therapy in addition to the general practitioners’ care, compared to 
the general practitioners’ care alone in patients with an acute lumbosacral radicular 
syndrome. Patients in general practice diagnosed with an acute (less than 6 weeks) 
lumbosacral radicular syndrome and an age above 18 years are eligible for participation. 
The general practitioners’ treatment follows their clinical guideline. The physical therapy 
treatment consists of patient education and exercise therapy. The primary outcome 
measure is the patient’s self-reported global perceived effect. Secondary outcome measures 
are severity of complaints, functional status, health status, fear of movement, medical 
consumption, sickness absence, costs and treatment preference. The follow-up is 52 weeks. 
Treatment by general practitioners and physical therapists in this study will be transparent 
and not a complete “black box”. 
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The results of this trial will contribute to the decision of the general practitioner regarding 
referral to physical therapy in patients with an acute lumbosacral radicular syndrome. 
 
Chapter 7 describes the results of the randomised clinical trial that aimed to assess the 
effectiveness of physical therapy in addition to the general practitioners’ care compared to 
the general practitioners’ care alone, in patients with an acute lumbosacral radicular 
syndrome. A total of 135 patients with an acute lumbosacral radicular syndrome (recruited 
from May 2003 to November 2004) were randomised in two groups: 1) the intervention 
group received physical therapy added to the general practitioners’ care, and 2) the control 
group with general practitioners’ care only. The outcomes were measured at 3, 6, 12 and 52 
weeks after randomisation. At 3-months follow-up, 70% of the intervention group and 62% 
of the control group reported improvement (RR 1.1; 95% CI 0.9; 1.5). At 12-months follow-
up, 79% of the intervention group and 56% of the control group reported improvement (RR 
1.4; 95% CI 1.1; 1.8). No significant differences in secondary outcomes were found at short-
term or long-term follow-up. In conclusion, at 12-months follow-up, evidence was found 
that physical therapy in addition to the general practitioners’ care is more effective in the 
treatment of patients with acute lumbosacral radicular syndrome than the general 
practitioners’ care alone. There are indications that physical therapy is particularly effective 
in patients reporting severe disability at presentation. 
 
In Chapter 8 we performed an economic evaluation alongside the randomised clinical trial, 
described in Chapter 7, and evaluated the cost-effectiveness of physical therapy and general 
practitioners’ care for patients with an acute lumbosacral radicular syndrome. The direct 
and indirect costs were measured by means of questionnaires in a 1-year follow-up period. 
The Incremental Cost Effectiveness Ratio (ICER) between both study arms was constructed. 
Confidence intervals for the ICER were calculated using Fieller’s method and using 
bootstrapping. There was a significant difference on perceived recovery at 1-year follow-up 
in favour of the physical therapy group. The additional physical therapy did not have an 
incremental effect on quality of life. At 1-year follow-up, the ICER for the total costs was € 
6224 (95% CI: -10419; 27551) per improved patient gained. For direct costs only, the ICER 
was € 837 (95% CI: -731; 3186). It is concluded that physical therapy did result in a higher 
level of perceived recovery, but provided no cost effective addition to care in general 
practice for patients with a lumbosacral radicular syndrome. 
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Samenvatting 
 
 
Het lumbosacraal radiculair syndroom kenmerkt zich door pijn in het been en 
belemmeringen in het functioneren, hetgeen vaak resulteert in een hulpvraag binnen de 
gezondheidszorg en ziekteverzuim op het werk. Binnen de huisartspraktijk is dit syndroom 
de meest voorkomende oorzaak van specifieke lage rugpijn. Het doel van het onderzoek 
beschreven in dit proefschrift was het vaststellen in welke mate huisartsen en 
neurochirurgen de patiënten met een lumbosacraal radiculair syndroom behandelen in 
vergelijking met hun richtlijnen, en het vaststellen van de (kosten)effectiviteit van 
fysiotherapie toegevoegd aan de huisartsbehandeling bij patiënten met een acuut 
lumbosacraal radiculair syndroom. 
 
Het onderzoek beschreven in hoofdstuk 1 beschrijft in welke mate huisartsen de patiënten 
met een lumbosacraal radiculair syndroom behandelden in vergelijking met hun richtlijn. 
Op baseline en na 6 maanden follow-up vulden 63 huisartsen vragenlijsten in over de 
ingestelde behandeling bij in totaal 136 individuele patiënten met een lumbosacraal 
radiculair syndroom. Tegelijkertijd werden deze 136 patiënten telefonisch geïnterviewd op 
baseline, en op 3 en 6 maanden follow-up. Van de 12 aanbevelingen in de richtlijn 
betreffende de anamnese, werden er vier niet opgevolgd door de huisartsen bij 25% van hun 
patiënten. Van de 10 aanbevelingen betreffende het lichamelijk onderzoek, werden er drie 
niet frequent uitgevoerd door de huisartsen. Bijna 40% van de patiënten werd naar de 
fysiotherapie verwezen en aan 27% werd spierverslappende medicatie voorgeschreven. De 
conclusie was dat huisartsen de richtlijn goed opvolgen ten aanzien van het afnemen van de 
anamnese en het uitvoeren van het lichamelijk onderzoek, en dat ze deze redelijk opvolgen 
wat betreft de ingestelde behandeling. 
 
In hoofdstuk 2 wordt beschreven in welke mate de neurochirurgen in Nederland de inhoud 
van de multidisciplinaire richtlijn ‘lumbosacraal radiculair syndroom’ onderschrijven. Deze 
richtlijn was samengesteld en gepubliceerd in 1996 door het Kwaliteitsinstituut voor de 
Gezondheidszorg CBO (Centraal BegeleidingsOrgaan). Alle in Nederland actieve 
neurochirurgen (n=92) werden uitgenodigd mee te werken aan dit onderzoek en een 
vragenlijst in te vullen over de 26 aanbevelingen uit deze multidisciplinaire richtlijn. 75% 
van de neurochirurgen reageerde en hiervan was 94% het (geheel of gedeeltelijk) eens met 
de inhoud van de richtlijn. Zeven van de 26 aanbevelingen uit de richtlijn werden niet 
(geheel) onderschreven door de neurochirurgen. Het onderzoek toonde aan dat bijna alle 
neurochirurgen de inhoud van de richtlijn (bijna geheel) onderschrijven. Dit betekent dat 
er voor de implementatie van die richtlijn aan een belangrijk aspect was voldaan namelijk 
het accepteren van de inhoud van de richtlijn ‘lumbosacraal radiculair syndroom’. 
 
In het onderzoek beschreven in hoofdstuk 3 werd onderzocht in welke mate 
neurochirurgen volgens de richtlijn ‘lumbosacraal radiculair syndroom’ handelen bij 
patiënten met een lumbosacraal radiculair syndroom. Bij 7 neurochirurgen werden de 
medische dossiers van 163 patiënten die waren geopereerd vanwege een lumbosacraal 
radiculair syndroom nader onderzocht. Met name de tijd tussen het ontstaan van de 
klachten en het moment van opereren was aanzienlijk groter dan voorgesteld in de richtlijn. 
 Dit onderzoek toonde aan dat op basis van het handelen bij patiënten met een lumbosacraal 
radiculair syndroom de neurochirurgen de aanbevelingen in de richtlijn grotendeels 
opvolgen. 
 
Het doel van het onderzoek beschreven in hoofdstuk 4 was te inventariseren wat de 
(middel)lange termijn uitkomsten zijn bij patiënten met een lumbosacraal radiculair 
syndroom op basis van een discus hernia op niveau L4-L5 of L5-S1 na operatie. Tevens 
werd nagegaan welke prognostische factoren samenhangen met aanhoudende klachten na 
een operatie op de (middel)lange termijn. In dit beschrijvend onderzoek werden bij 163 
geopereerde patiënten gemiddeld 6 en 19 maanden na operatie telefonische vragenlijsten 
afgenomen. 63% van de patiënten rapporteerde op (middel)lange termijn nog in meer of 
mindere mate klachten te hebben gerelateerd aan het lumbosacraal radiculair syndroom. De 
ernstige beenpijn nam met 83% af en de patiënten waren tevreden over de ontvangen 
behandeling. Het geslacht (vrouw) en een leeftijd van 51-65 jaar bleken prognostische 
factoren voor aanhoudende LRS klachten op de (middel)lange termijn. Geconcludeerd 
werd dat veel patiënten op de (middel)lange termijn nog lumbosacraal radiculair syndroom 
gerelateerde klachten rapporteerden. 
 
In hoofdstuk 5 wordt een systematische review beschreven waarin de effectiviteit van 
conservatieve behandelingen bij het lumbosacraal radiculair syndroom werd onderzocht. 
Relevante studies werden gezocht in electronische databases en de referenties van 
publicaties tot mei 2004. Door twee reviewers werden gerandomiseerde klinische trials 
geïncludeerd met allerlei conservatieve behandelingen bij patiënten met een lumbosacraal 
radiculair syndroom. Twee reviewers beoordeelde, onafhankelijk van elkaar, de 
methodologische kwaliteit en de klinische relevantie van deze studies. Er was besloten geen 
meta-analyse uit te voeren omdat de studies te heterogeen waren. De resultaten van de 
studies zijn samenvattend weergegeven waarbij gebruik is gemaakt van de ‘levels of 
evidence’. Er werden 30 trials geïncludeerd die injecties, tractie therapie, fysiotherapie, 
bedrust, manipulatie, medicatie, en acupunctuur onderzochten. Uit de resultaten van de 
review werd geconcludeerd dat corticosteroïd injecties en/of tractie niet zijn aan te bevelen 
vanwege het gebrek aan bewijs voor een effect. Of artsen fysiotherapie, bedrust, 
manipulatie, of medicatie moeten voorschrijven kon niet worden bepaald uit deze review. 
Op dit moment is er geen bewijs dat één type behandeling superieur is boven de anderen, 
inclusief géén behandeling, voor patiënten met een lumbosacraal radiculair syndroom. 
 
In hoofdstuk 6 wordt het ‘design’ van een gerandomiseerde klinische trial (RCT) 
beschreven die de effectiviteit onderzoekt van fysiotherapie toegevoegd aan de 
huisartsbehandeling vergeleken bij de huisartsbehandeling alleen, bij patiënten met een 
lumbosacraal radiculair syndroom. Patiënten uit de huisartsenpraktijk die zijn 
gediagnostiseerd met een acuut (minder dan 6 weken) lumbosacraal radiculair syndroom 
en met een leeftijd van 18 jaar of ouder zijn geschikt voor deelname. De huisartsen dienen 
voor de behandeling van deze patiënten hun richtlijn aan te houden. De fysiotherapie zal 
bestaan uit voorlichting over het syndroom en actieve oefentherapie. De primaire 
uitkomstmaat is het door de patiënt ‘ervaren herstel’. Secundaire uitkomstmaten zijn ernst 
van de (pijn)klachten, functionele belemmeringen, algemene gezondheidstoestand, angst 
voor bewegen, medische consumptie, kosten en voorkeur voor behandeling. De follow-up is 
52 weken. 
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De behandeling van de huisarts als die van de fysiotherapeut(e) zijn transparant en niet een 
gehele ‘black box’. Het is de bedoeling dat de resultaten van dit onderzoek de huisarts 
ondersteunen in zijn of haar beslissing om een patiënt met een lumbosacraal radiculair 
syndroom al dan niet te verwijzen naar fysiotherapie. 
 
Hoofdstuk 7 beschrijft de resultaten van de gerandomiseerde klinische trial die de 
effectiviteit onderzocht van fysiotherapie toegevoegd aan de huisartsbehandeling vergeleken 
met de huisartsbehandeling alleen, bij patiënten met een lumbosacraal radiculair syndroom. 
De 135 gerekruteerde (van mei 2003 tot november 2004) patiënten werden gerandomiseerd 
in twee groepen: 1) de interventiegroep; die fysiotherapie ontving toegevoegd aan de 
huisartsbehandeling, en 2) de controle groep; die alleen de huisartsbehandeling ontving. De 
uitkomstmaten werden gemeten op baseline en op 3, 6, 12, en 52 weken follow-up. Op 12 
weken follow-up, rapporteerden 70% van de patiënten in de interventiegroep en 62% van de 
patiënten in de controle groep herstel (RR 1.1; 95% CI 0.9; 1.5). Op 52 weken follow-up, 
rapporteerden 79% van de patiënten in de interventiegroep en 56% van de patiënten in de 
controle groep herstel (RR 1.4; 95% CI 1.1; 1.8). In de secundaire uitkomstmaten werden 
geen statistisch significante verschillen gemeten op de korte en lange termijn follow-up. De 
conclusie uit de resultaten was dat op 52 weken follow-up, fysiotherapie toegevoegd aan de 
huisartsbehandeling effectiever is dan de huisartsbehandeling alleen, bij patiënten met een 
lumbosacraal radiculair syndroom. Er zijn indicaties dat fysiotherapie vooral effectiever is 
bij patiënten die ernstige functionele belemmeringen rapporteren bij de presentatie van hun 
klachten. 
 
Het onderzoek in hoofdstuk 8 evalueerde de kosteneffectiviteit van fysiotherapie en 
huisartsbehandeling bij patiënten met een lumbosacral radiculair syndroom. Een 
economische evaluatie was uitgevoerd tegelijk met de gerandomiseerde trial beschreven in 
hoofdstuk 7. De directe en indirecte kosten waren gemeten met vragenlijsten gedurende de 
52 weken follow-up. De Incremental Cost Effectiveness Ratio (ICER) tussen beide groepen 
werd geconstrueerd. De betrouwbaarheidsintervallen (CI) voor de ICER waren berekend 
met de methode van Fieller en middels ‘bootstrapping’ technieken. Er was een significant 
verschil op ervaren herstel na 1 jaar follow-up in het voordeel voor de groep die 
fysiotherapie ontving. De toegevoegde fysiotherapie had geen effect op de ‘kwaliteit van 
leven’. Na 1 jaar follow-up was de ICER voor de totale kosten € 6224 (95% CI: -10419; 
27551) per herstelde patiënt. De ICER voor alleen de directe kosten was € 837 (95% CI: -
731; 3186). Concluderend, blijkt dat de toevoeging van fysiotherapie aan de 
huisartsbehandeling meer patiënten die herstel ervaren, maar niet kosteneffectief is, voor 
patiënten met een lumbosacraal radiculair syndroom. 
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